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The ribosome is a megadalton complex that performs protein synthesis with 
tremendous speed and accuracy. Atomic resolution ribosome structures have been 
resolved within the last five years. These have provided the 3-dimensional locations 
of all ribosomal components, and have revealed structures of the active centers. 
However, the precise mechanisms of the various functions performed by the ribosome 
are still unknown. This work is an attempt to understand some of the functional 
relationships between different active centers of the ribosome (or the “wiring” of the 
ribosome), and mechanisms by which such communication occurs. Here we present 
an analysis of three ribosomal components: ribosomal proteins L3 and L10, and 5S 
rRNA. Studies of L3 suggest that accommodation of aminoacyl-tRNAs (aa-tRNA) 
may be the mechanism that induces the “active” conformation of the peptidyl 
transferase center. We have proposed a mechanism in which rRNA movement 
associated with aa-tRNA accommodation facilitates conformational changes in the 
  
peptidyl transferase center (PTC) through the formation of a network of hydrogen 
bond interactions. A saturation mutagenesis analysis of 5S rRNA disproves the 
previous notion that 5S rRNA is a resilient molecule. An analysis of naturally 
occurring 5S rRNA variants suggests that this molecule may participate in 
posttranscriptional regulation of gene expression via the nonsense-mediated mRNA 
decay (NMD) pathway. Lastly, a random mutagenesis analysis of ribosomal protein 
L10 has resulted in the creation of a powerful toolbox that will be used for elucidation 
of ribosome export/maturation pathways. Future structure/functional analyses of these 
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Chapter 1.  Literature review 
Introduction 
The ribosome is the largest RNA-protein complex in the cell. It translates the 
information contained in mRNAs into polypeptide chains, thus linking the worlds of 
nucleic acids and proteins.  In the late 1990's, the combined efforts of several groups 
resulted in the elucidation of ribosomal structure at the atomic level 1,2. The three 
dimensional (3-D) structure revealed the contacts and relative positions of most of the 
ribosomal components. Together with previously accumulated biochemical data, 
those studies gave birth to multiple hypotheses regarding the roles of individual 
ribosomal components, most of which failed subsequent empirical testing.  Currently 
the exact mechanisms through which the ribosome performs its functions are still 
unclear. This work describes our attempts to understand the roles of individual 
ribosomal components in translation. 
Initiation 
Translation consists of three phases: initiation, elongation, and termination. 
Initiation is the first step of the cycle. During initiation, mRNA forms a complex with 
ribosome, which then recognizes and selects the appropriate start codon and begins 
translation in the correct reading frame.  
 The majority of eukaryotic mRNAs have 5’ 7mG caps and poly A tails, 
structural features recognized by cellular translational factors that are required for 
efficient translation initiation 3,4. Initiation can be divided into consecutive steps: 43S 




formation, 5'→3' scanning, initiation codon recognition, and 60S subunit joining 
(Figure 1.1) 5. The first step is formation of the 43S pre-initiation complex. The 
ternary complex formed by eIF2, GTP and Met-tRNAMet binds to the free 40S 
ribosomal subunit; where it then recruits eIF1, eIF1A, eIF3 and eIF5. The binding of 
eIF3 finalizes assembly of pre-initiation complex and renders it competent for mRNA 
interaction. The 43S complex gets recruited to mRNA by initiation factor 4F (eIF4F), 
to form the 48S initiation complex 5,6. eIF4F is a hetero-tetramer, composed of the 
eIF4A, eIF4B, eIF4E and eIF4G subunits 7. eIF4E binds the mRNA cap structure and 
recruits eIF4G. As a scaffolding protein, eIF4G has three particularly important sets 
of interactions. First, eIF4G interacts with poly A binding protein (PABP), 
circularizing the mRNA and bringing translation regulatory sequences located in the 
3' UTR close to the initiation complex 8,9. Second, eIF4G interacts with eIF3, which 
in turn recruits the 60S ribosomal subunit to mRNA. Third, it recruits eIF4A and 
eIF4B, which have ATP dependent RNA helicase activities 10,11. After formation of 
the 48S initiation complex, eIF1 and eIF1A act synergistically to enable scanning in 
the 5' to 3' direction 12. Scanning is ATP dependent and continues to the initiation 
codon 13. The exact way in which the proper AUG codon is recognized is unknown. It 
has been proposed that basepairing between the anticodon stem loop of tRNAMet and 
the AUG codon triggers GTP hydrolysis by eIF5 and eIF2. The hydrolysis of GTP 
leads to the displacement of eIF2:GDP and the rest of the initiation factors, allowing 
60S subunit joining. This results in formation of an elongation competent 80S 










There are also multiple examples of cap independent initiation in viruses and 
higher organisms. It includes substitution of the cap by a specific mRNA binding 
protein, or initiation at Internal Ribosome Entry Sites (IRES’es). The mechanisms of 
the cap independent initiation are diverse and each differs from one another. 
Structural determinants in mRNAs that define efficient initiation, sets of required 
canonical translation factors, and use of non canonical cellular or viral factors for 
initiation. The size of IRES'es can vary from tens to hundreds of nucleotides, and the 
set of required factors may vary from none (e.g. for the Cricket Paralysis Virus IRES 
15,16) to use both canonical factors and non-canonical initiation proteins (e.g. the 
Hepatitis C Virus IRES 17,18). It appears that there are no obvious correlations 
between different IRESes in conditions required for initiation, and they differ on 
case-to-case basis. 
The elongation cycle 
The elongation cycle contains three major steps: aminoacyl-tRNA (aa-tRNA) 
selection, peptidyl transfer, and translocation. First, the ternary complex of EF-
Tu:GTP:aminoacyl-tRNA (eEF-1:GTP:aminoacyl-tRNA in eukaryotes) brings 
correct tRNAs into the A-site of the ribosome. Next, aminoacyl-tRNA binding is 
followed by thermodynamically spontaneous formation of the peptide bond and 
transfer of the peptidyl moiety to the A-site tRNA 19. Finally, elongation factor EF-G 
(eEF-2 in eukaryotes) catalyzes translocation. Translocation involves replacement of 
the deacylated tRNA by the peptidyl-tRNA in the P-site of the ribosome, and 






Figure 1.2. The allosteric model of the elongation cycle. 
The elongation cycle includes three major steps: aminoacyl-tRNA selection, peptidyl transfer and 
translocation. First step is selection of the correct A-site tRNA as part of the ternary complex of 
composed of EF-Tu:GTP:aminoacyl-tRNA. Binding of the aminoacyl-tRNA to the A-site triggers 
release of the E-site tRNA from the E-site. Aminoacyl-tRNA binding is followed by spontaneous 
formation of the peptide bond and transfer of the peptidyl moiety to the A-site tRNA. Finally, 
elongation factor EF-G catalyzes translocation, which involves movement of the peptidyl tRNA 
from the A-site to the P-site of the ribosome, shift of the deacylated tRNA from the P-site to the E-





Selection of the correct aminoacyl-tRNA is the first step of the elongation 
cycle. Numerous studies of translational fidelity and kinetics of aminoacyl-tRNA 
selection have been distilled into the “kinetic proofreading” model of A-site tRNA 
selection 21,22. This model postulates that aminoacyl-tRNA discrimination by the 
ribosome takes place in two major steps: initial selection before, and proofreading 
after GTP hydrolysis. It includes six intermediate steps: (1) initial binding, (2) codon 
recognition, (3) EF-Tu (eEF-1 in eukaryotes) conformation change and GTPase 
activation, (4) GTP hydrolysis by EF-Tu and phosphate release, (5) dissociation of 
EF-Tu from the ribosome, and (6) either accommodation of the aminoacyl-tRNA into 
the A/A site or its rejection and dissociation from the ribosome (Figure 1.3) 23. 
Initial binding is a rapid and non-specific step that places the aminoacyl-tRNA 
into the A/T site on 80S subunit. At this stage, the anticodon end of the aminoacyl-
tRNA is located in the decoding center, and the acceptor end of the aa-tRNA does not 
interact with the ribosome and occupies the so called T-site 24,25 i. Subsequent 
formation of codon - anticodon base pairs between tRNA and mRNA stabilizes the 
ribosome - cognate tRNA complex 26-28, while non- and near- cognate tRNAs that fail 
to form codon - anticodon helices rapidly dissociate from the ribosome 26-28.  Thus 
codon recognition is the first selective step of the aa-tRNA selection. The 
crystallographic studies of T. thermophilus ribosomes illustrated that base pair  
  
                                               
i T-site is not really a site, because the acceptor end of the aa-tRNA does not interact with the active 
centers of the ribosome. However it establishes contacts with the surface side of the ribosome. Also, in 
contrary to the other ribosomal sites, tRNA could not bind to the T-site only. This term rather should 

























Figure 1.3. Kinetic proofreading model of aminoacyl-tRNA selection.  
Kinetically resolved steps are indicated by rate constants k1 − k7, k−1, k−2 and the two chemical steps 
that are rate-limited by the preceding step are designated kGTP and kpep.   The selection of proper 
aminoacyl-tRNA includes two phases:  initial selection and proofreading. GTPase activation and 
reverse reaction of codon recognition are selective steps in the initial phase. Accommodation is the 




formation is monitored through a complex network of interactions with 16S rRNA 30. 
The universally conserved A1493 (in helix 44ii, base numbering according T. 
thermophilus) binds in the minor groove of the first codon-anticodon base pair 
(counting from the 5’ to the 3’ end of mRNA). The second base pair is monitored 
through interactions between A1492, G530 and the minor groove of the second pair. 
In the third pair, C1054 (in T. thermophilus, h34) stacks against the first base of the 
anticodon. The third base of the mRNA codon directly interacts with G530, through a 
magnesium ion with C518, and amino acid residue P48 (in T. thermophilus) of 
protein S12 (S13 in S. cerevisiae, Figure 1.4). Formation of this network of 
interactions promotes conformational changes in h34 and h44 of 16S rRNA, as well 
as in the aminoacyl-tRNA. These conformational changes then triggers structural 
changes in the large subunit and EF-Tu 31. Thus, activation of EF-Tu is induced by 
formation of the codon-anticodon helix, which is followed by rapid GTP hydrolysis. 
Kinetic studies suggest that rates of GTP hydrolysis are the same for cognate and 
non-cognate tRNAs and they are strongly induced by preceding conformational 
changes 28,31,32.  Upon GTP hydrolysis and phosphate release, EF-Tu adopts the GDP 
bound conformation 33,34 and rapidly dissociates from the tRNA and the ribosome 35. 
The kinetic parameters of dissociation are similar for cognate and near cognate 
tRNAs and do not limit subsequent steps 36.  EF-Tu release is followed by 
accommodation. Accommodation includes movement of the 3' end of the aa-tRNA 
into the peptidyl transferase center (PTC) 37, formation of specific interactions 
between the 3'-CCA end of aminoacyl-tRNA and residues in the inner core of  
 
                                               







Figure 1.4. Codon recognition at the decoding center. 
The tightness of the interactions is shown by the semitransparent van der Waals surface. A. In the 
first position, A1493 binds in the minor groove of the A36-U1 base pair. B. In the second position, 
G530 and A1492 (both brown) act in concert to monitor the A35-U2 base pair. C. The third G34-U3 
base pair is monitored by C1054, G530 and C518. C1054 stacks against G34 of the anticodon stem 
loop (ASL). U3 interacts with G530, and indirectly through an Mg2+ ion (magenta) with C518 and 




peptidyl transferase center  (A-loop [aka h38] and  h92 of 23S rRNA) 38, and finally, 
adoption of the active conformation by the PTC 39,40. Alternatively, at this step tRNA 
can be rejected and dissociate from the ribosome. The rate of accommodation is 
approximately 70 times lower and the rate of rejection is at least 20 times higher for 
the near-cognate tRNA compared to the cognate tRNA 21,23. Thus, accommodation 
represents the second selective step in aminoacyl-tRNA discrimination.  
Accommodation 
The process of accommodation has been computationally simulated 37.  Prior 
to accommodation, the aa-tRNA occupies the A/T state. At this stage, the anticodon 
end of tRNA occupies the decoding center, and the acceptor end is kinked out in the 
D-loop region and is relatively free of interactions with ribosome. The aminoacyl-
tRNA acceptor end establishes contacts with the GTPase associated center, (E. coli 
A1060, S. cerevisiae A1235, in h40), the tip of h89 (E. coli U2473, S. cerevisiae 
U2841), and the sarcin-ricin loop (E. coli A2660 and G2661; S. cerevisiae A3026 and 
G3027).  At early stages of accommodation, the acceptor end slides smoothly along 
h89 and h90 until it pauses at the first of two “gates”. This gate is formed by two 
nucleotides that lay at the base of h89 (E. coli U2492, S. cerevisiae U2860) and in the 
A-loop (h92, E. coli C2556, S. cerevisiae C2924). These two bases sterically interfere 
with progression of the 3’-CCA end into the peptidyl transferase center. Both the 
acceptor end of the tRNA and the A-loop of 23S rRNA flex to allow transition 
through this gate. Immediately after passage through the first gate, the 3’-CCA end 
clashes with U2573 (h92, E. coli, S. cerevisiae U2841), pausing for a second time. 




(E. coli C2556 and U2573; S. cerevisiae C2924 and U2941) and establishes 
interactions with residues in the inner core of the peptidyl-transferase center. Notably, 
h89, h90, and h92 together with ribosomal protein L16 (S. cerevisiae L10) guide the 
aa-tRNA during accommodation and constantly monitor its position. Thus, these 
residues may be involved aa-tRNA selection, and may participate in conformational 
changes that required for downstream reactions of the elongation cycle. 
This computational simulation provides an explanation for the proofreading 
mechanism during accommodation. Before accommodation, the aminoacyl-tRNA 
adopts a distorted conformation. First, the kink in the flexible “variable loop” at the 
anticodon end is associated with formation of codon-anticodon helix 41. Second, the 
major kink in the D-loop region of tRNA displaces the acceptor end of the molecule 
(Figure 1.5) 25, which puts the acceptor end outside of the A-site. Accommodation 
relaxes the aminoacyl-tRNA and allows it to adopt a conformation that more closely 
resembles its solution state. Thus the initial conformation of the aa-tRNA would 
likely affect the trajectory of the 3’-CAA end, and the ability of the acceptor end to 
pass through two gates. Near- and non-cognate aminoacyl-tRNAs fail to promote the 
conformational changes associated with codon recognition 21,42. Thus during 
accommodation of these tRNAs the amino acceptor end may move along a different 
trajectory, which may affect ability of the tRNA to pass through accommodation 













Figure 1.5. Conformational changes associated with accommodation and codon recognition. 
A. tRNA conformation in the EF-Tu ternary complex. B. tRNA after codon recognition is shown 
in purple. Codon recognition triggers conformational changes in the variable loop and promotes 
the kink of the anticodon arm, designated by the dashed line. C. Superimposition of the tRNA 
structure before (shown in green) and after accommodation (shown in orange). During 
accommodation tRNA relaxes and adopts a conformation which mostly resembles the 





Accommodation of aminoacyl-tRNA is followed by peptidyl transfer. This 
catalytic activity is mediated entirely by the 23S rRNA, thus the ribosome is a 
ribozyme. The 3-D structure of the ribosome demonstrated that the peptidyl 
transferase center is entirely composed of the 23S rRNA 43,44, and no proteins or 
conserved metal ions come within 18Å of the active site 45. Recent structural studies 
suggest an induced fit mechanism of peptidyl transferase activation 39. Binding of the 
A-site substrate induces structural rearrangements in the PTC, specifically affecting 
the bases in the loop between h89-90 and h90-93. In this conformation, the ester bond 
between the P-site tRNA and the peptide chain becomes accessible for nucleophilic 
attack by the primary amino group of the A-site substrate (Figure 1.6). Despite 
advances in crystallography and biochemical characterization of the peptidyl transfer, 
the precise mechanism of the peptidyl transfer is still unknown. Multiple hypotheses 
have proposed acid-base 46, substrate assisted 47,48 and proximity mechanisms 49,50. 
Many different functional groups have been implicated as actively participating in 
catalysis. These include: the primary amino group of A2451 (in E.coli, S.cerevisiae 
A2841) 40, the 2’-OH of the A2451 ribose 51, the N3 ring nitrogen of A2451, and 2’-
OH of A76 of peptidyl-tRNA 47,52. 
Translocation 
Following formation of the peptide bond, the tRNA:mRNA complex must be 
translocated in the 3’ direction by precisely three nucleotides. Consequent to 





Figure 1.6. Induced fit conformational changes in PTC 
Structures of the ribosome in uniduced, induced conformations, and in the complex with the 
transition state analog (TSA). A. A-site. B. P-site. The rRNA in uniduced conformation is shown in 
gray and in the induced conformation it is shown in orange. A-site substrate for uninduced 
conformation is shown in pink and for induced conformation in purple. The P-site substrate in 
uninduced conformation is shown in green and in induced conformation in light green. The 
transition state analog (TSA) which is thought to mimic transition intermediate during peptidyl 
transfer is shown in black. The rRNA of the ribosome in the complex with TCA is shown in dark 
brown. The proposed movements of the RNA bases are indicated by arrows. Modified from Pape T., 




deacylated tRNA moves into the E-site. Efficient translocation requires EF-G and 
GTP hydrolysis. However the requirement for EF-G:GTP can be waived, albeit the 
non-enzymatic translocation is ~100 fold slower . The exact mechanism of 
translocation is also unknown. There are currently a few hypotheses describing the 
movement of the tRNAs during translocation. An initial “three site model” described 
translocation as a single simultaneous movement of the peptidyl-tRNA from the A-
site into the P- site, and deacylated tRNA into the E-site without the any intermediate 
steps. The “allosteric three site model” extends this hypothesis. It proposes that: 1) 
before translocation the E-site is unoccupied; 2) translocation involves movement of 
the deacylated tRNA into the vacant E-site; and 3) binding of the incoming 
aminoacyl-tRNA to the A-site promotes dissociation of the deacylated tRNA from the 
E-site, thus preparing it for the next round of translocation 20,53,54. Alternatively, the 
hybrid states model implies that spontaneous movement of both acceptor ends occurs 
after peptidyl transfer. This movement shifts the acceptor end of the A-site tRNA into 
the P-site and acceptor end of the P-site tRNA into E-site, thus placing the peptidyl-
tRNA into the hybrid A/P site and the deacylated tRNA into the P/E site. EF-G 
completes translocation and promotes movement of the tRNAs into the P/P and A/A 
sites (Figure 1.7) 55. Chemical footprinting 55,56 and fluorescence experiments 57 
support the existence of hybrid states, and cryo-EM reconstruction at high magnesium 
concentration tentatively demonstrated tRNA in the hybrid position 58. In contrast, 
toeprinting experiments, biochemical assays, computational simulations, and the bulk 
of the structural data 41,59 have not been able to confirm the existence of this 





Figure 1.7. The hybrid states elongation model. 
Spontaneous movement of the acceptor ends of the peptidyl and deacylated tRNAs occurs after 
peptidyl transfer. This movement places peptidyl-tRNA into the hybrid A/P site and deacylated 
tRNA into the P/E site. EF-G finalizes translocation and promotes movement of the tRNAs into P/P 




The molecular mechanism of translocation is unclear. The resemblance of 
overall shape between the ternary complex of EF-Tu:GTP:aa-tRNA and EF-G:GTP 
(“molecular mimicry”, Figure 1.8) suggests that these factors may function in a 
similar manner. The structural resemblance between the anticodon stem loop of tRNA 
in EF-Tu:GTP:aa-tRNA suggests that during translocation the EF-G extension finger 
may fit into the A-site on the small subunit thus displacing the peptidyl-tRNA from 
the A-site and leveraging it into the P-site 61. This position of the EF-G finger was 
observed in cryo-EM structures of EF-G:ribosome complexes, suggesting that 
displacement of the A-site tRNA by EF-G may be the driving force of translocation 
62. 
Termination 
Termination is the final stage of translation process. It includes the hydrolysis 
of the ester bond between the P-site tRNA and polypeptide chain and release of the 
newly synthesized protein from the ribosome. Termination is triggered by the 
presence of a stop codon in the A-site of the ribosome and promoted by the release 
factors (Figure 1.9). There are two classes of release factors, denoted class I and class 
II 63. Class I release factors decode the stop codon in the A-site of the ribosome and 
promote ester bond hydrolysis by the large subunit of the ribosome 64,65. Class II 
release factors stimulate activity of the class I factors and tune their specificity. 
Prokaryotes have two class I release factors, RF1 and RF2, and one class II factor, 
RF3. RF1 recognizes UAA and UAG, and RF2 recognizes UAA and UGA codons 66. 
The RF3 can stimulate both factors to recognize all three stop codons and is also 





Figure 1.8. Ternary structures of EF-Tu and EF-G. 
EF-G in the GTP bound form resembles the ternary complex of EF-Tu:GTP:aa-tRNA. The structure 
of EF-Tu:GTP:Phe-tRNAPhe is from Kristensen O., et al 69 and the structure of EF-G is from Hansso 







Figure 1.9. Translation termination in eukaryotes 
Termination is triggered by the presence of the stop codon in the A-site of the ribosome. The stop 
codon recognition by the eRF1 or eRF1:eRF3:GTP complex promotes ester bond hydrolysis 
followed by the GTP hydrolysis by eRF3 and dissociation of the factors from the ribosome. From 






Eukaryotes have only one class I factor (eRF1) which is responsible for recognition 
of all three stop codons 71. In contrast to elongation factors which are conserved 
among different kingdoms, there are no similarities in either primary or in ternary 
structures between free class I prokaryotic factors and eRF1 72,73. Thus, either the 
mechanism of termination is not conserved, or these proteins diverged beyond the 
simple similarity recognition. In fact, while the ternary structures of the free 
translation factors are dissimilar, the structure of eRF1 in complex with ribosome 
resembles the shape of free RF1, thus suggesting the possibility of divergent 
evolution 74,75. Eukaryotes also have the single class II factor eRF3. RF3 and eRF3 do 
not posses any similarity at the level of primary structure, except in the GTP binding 
motif. Also in contrast to prokaryotes, eRF3 forms a cytosolic complex with eRF1, 
while no such complex has been observed in prokaryotes 76,77. Since the conservation 
of the termination mechanism through evolution is unclear we decided to focus on the 
termination in eukaryotes to prevent further confusion. 
In eukaryotes, termination includes three stages. First, the presence of a stop 
codon in the A-site is decoded by eRF1 or the eRF1:eRF3:GTP complex. This 
complex triggers hydrolysis of the ester bond. It is thought that this is followed by 
eRF3 mediated GTP hydrolysis and dissociation of these factors from the ribosome 
(Figure 1.9). The exact mechanism of termination is unclear. The resemblance of the 
overall shape of the class I factors and ternary complex of the EF-Tu:GTP:aa-tRNA 
promoted a molecular mimicry hypothesis 78. In this concept, the overall resemblance 
between the ternary complex and the release factors is thought to allow termination 
factors to interact with the ribosome and function in the way similar to the ternary 




studies identified the presence of the protein “anticodon” in RF1 and RF2. The three 
amino acid sequences PAT and SPF determine selectivity of RF1 and RF2 
correspondingly to the specific stop codon 79,80. However genetic studies of eRF1 did 
not reveal such a discriminatory motif; rather the entire domain that interacts with 
mRNA is responsible for mRNA recognition (Figure 1.10) 81,82. 
Stop codon recognition is followed by ester bond hydrolysis. Genetic studies 
identified the universally conserved GGQ motif, which is required for activation of 
peptidyl-tRNA hydrolysis. However the role of the GGQ motif in hydrolysis is 
unclear. It was proposed that binding of release factor to the ribosome rearranges its 
ternary structure and places the GGQ motif in the peptidyl transferase center 74,83. 
Two possible mechanisms were suggested. First, the glutamine residue may be 
involved in coordination of the water molecule, thus promoting nucleophilic attack by 
the water molecule 72. However, mutagenesis studies demonstrated that mutations in 
this position did not affect the ability of eRF1 to promote ester bond hydrolysis 84, 
while two adjacent glycine residues are essential for this function 85. Alternatively, 
hydrolysis may be catalyzed by the peptidyl transferase center of the ribosome, while 
termination factors trigger the conformational changes in the PTC but do not actively 
participate in catalysis 85. The recently proposed induced fit hypothesis suggests a 
possible mechanism of ester bond hydrolysis. As was previously discussed (Chapter 
1. Peptidyl transfer), binding of the EF-Tu:GTP:aa-tRNA to the A-site of the 
ribosome triggers conformational changes in the PTC (Figure 1.6). These structural 











Figure 1.10. Ternary structures of class I release factors. 
The E. coli RF-2 (from Vestergaard B., et al 73) and of H. sapiens eRF-1 (from Song H., et al 72) do 
not share similarities in primary nor ternary structures. The mRNA interacting regions are shown in 







tRNA from nucleophilic attack by the primary amino group of the aa-tRNA 39. It was 
suggested that termination factors might trigger the same kind of movement in the 
PTC, which in absence of aa-tRNA would result in hydrolysis of the ester bond by 
water. In support of this model, fitting of theoretical water molecules in the 3-D 
ribosomal structure demonstrated that in the uninduced state the ester bond is 
protected from water mediated nucleophilic attack by the A2486 and U2620 bases (in 
H. marismortui, S. cerevisiae A2819 and U2953). Movement of U2620 during the 
adoption of the active conformation would allow a water molecule to enter into the 
PTC, thus permitting the hydrolysis of the ester bond (Figure 1.11) 39. In accordance 
with this hypothesis the GGQ motif would be involved in PTC activation rather than 
directly participating in catalysis. 
eRF3 mediated GTP hydrolysis follows cleavage of the ester bond and 
promotes dissociation of the release factors from the ribosome. The exact mechanism 
of GTPase activation and role of GTP hydrolysis during eukaryotic termination is 
unknown. The mechanism of function of eRF3 is likely to be distinct from RF3. In 
prokaryotes, RF3 binds the ribosome in the GDP bound form. Subsequent cleavage of 
the ester bond promotes GTP exchange, which triggers dissociation of the class I 
factors from the ribosome 67. It is thought that following GTP hydrolysis by RF3 is 
required for subsequent RF3 dissociation from the ribosome 67,86. In contrast to 
eukaryotes, eRF3 does not require a class I factor for GTP exchange and binds to the 
ribosome in its GTP bound form. It was proposed that GTP hydrolysis by eRF3 may 






Figure 1.11. Proposed mechanism of ester bond hydrolysis between the peptidyl-tRNA and 
new polypeptide chain. 
The ribosome in uninduced conformation (depicted above) sterically excludes water from the 
PTC. The proposed movement of U2620 (in H. marismortui, indicated by the black arrow) upon 
adoption of the induced conformation would allow a water molecule to enter into the peptidyl 
transferase center in absence of the A-site substrate. Release factors may function in a similar 
manner as the A-site tRNA and promote such movement, which in the absence of the aa-tRNA in 
the A-site would result in hydrolysis of the bond between peptidyl-tRNA and polypeptide chain. 





RF3 86. It is possible that eRF3 is result of regressive evolution of RF3. The 
requirement of nucleotide exchange for class I factor release may have been lost 
during evolution, while GTP hydrolysis is still required for release of class II factors 
from the ribosome. Thus, the functions of the prokaryotic and eukaryotic class II 
factors could be at least partially similar. 
Translational recoding 
During the elongation cycle, the ribosome moves along the mRNA decoding 
nucleotide triplets, eventually terminating at the stop codon. However, multiple 
examples of translational “recoding events” that disrupt frame maintenance are 
known to occur. Examples include long “hops” of 50 nucleotides or more, slips of a 
few bases in either direction, and “shunts” around large mRNA structures 87,88.  
Nonsense codon suppression 
Nonsense suppression is one such recoding event. There are two different 
types of the nonsense suppression: programmed and non-programmed. Programmed 
stop codon suppression occurs in response to downstream cis- signals in mRNA and 
trans-acting factors. This is a conserved mechanism for selenocysteine incorporation 
in all three kingdoms of life (except higher plants and fungi), and for pyrrolysine 
incorporation in bacteria. Incorporation of these amino acids happens with nearly 
100% efficiency 89-91. Non-programmed nonsense codon suppression (later referenced 
as nonsense suppression) occurs as result of stop codon decoding by natural 
suppressor tRNAs 92, and its efficiency depends on the intrinsic ability of the 
ribosomes to distinguish between the EF-Tu:GTP:aa-tRNA ternary complex and 




For example, E. coli, tRNAGln suppresses all three stop codons 93,94. In Tetrahymena 
thermophila GlnUmUCtRNA
iii, GlnUmUCtRNA  and 
Gln
UmUAtRNA  can also decode all three stop 
codons95,96, and in Methanococcus jannaschii stop codons encoded by tRNATyr 97. In 
S. cerevisiae GlnCUGtRNA  is able to decode the UUA and UUG codons, and 
Gln
UUGtRNA can decode UUG 
98,99. Notably, non-programmed nonsense suppression can 
be influenced by the surrounding mRNA context 92,100. The significance and 
mechanism of this effect is currently unknown. However it is thought that in general, 
non-programmed nonsense suppression occurs as result of the non specific 
incorporation of the amino acid at a termination codon. Genetic studies have 
determined a large number of mutations in tRNAs, eEF-1, termination factors and 
ribosomal proteins that affect nonsense suppression, thus reinforcing a notion that this 
kind of nonsense suppression depends on the ability of the ribosome to properly 
decode stop codon 101. Through out our studies we have utilized nonspecific nonsense 
suppression as the tool to assess translational fidelity.  
Programmed -1 Ribosomal Frameshifting 
Programmed -1 Ribosomal Frameshifting (-1PRF) is another translational 
recoding event, and it is widely used by viruses and transposable elements to regulate 
expression of structural and enzymatic proteins. -1PRF signals have been identified 
and characterized from the Severe Acute Respiratory Syndrome  virus (SARS-CoV) 
102, Human Immunodeficiency Virus (HIV-1) 103, Infectious Bronchitis Virus (IBV) 
104, the L-A virus 105 and many others. More recent studies have demonstrated that 
                                               
iii Here superscript designates amino acid specificity of the tRNA and subscript designates an 




-1PRF is not unique to viruses, and that functional -1 frameshift signals are present in 
the yeast 106, mouse 107-109, and human genomes 107,110.  
-1PRF is directed by two cis acting mRNA signals: a heptameric nucleotide 
slippery site N NNW WWHiv (the incoming 0-frame is indicated by spaces) 
immediately followed by an mRNA pseudoknot or strong stem loop (Figure 1.12). 
During -1PRF, translating ribosomes stall at the pseudoknot, pause over the slippery 
site, and slip by 1 base in the 5’ direction. Eventually, the ribosomal helicase resolves 
the pseudoknot and translation resumes in the -1 frame 88. The “simultaneous slippage 
model” was the first proposed mechanism of -1PRF 103. In this model, the ribosome 
stalls over the slippery site and the A- and P-site tRNAs simultaneously slip one base 
in the 3’ direction and then re-pair in the new frame (Figure 1.13). The original model 
did not define when -1PRF happens. However since the mRNA moves by 3 
nucleotides during the each translocation step of the elongation cycle, it was assumed 
that -1PRF is a “distorted” translocation step and that slippage occurs co-
translocationally. However, genetic and pharmacological evidence show that 
alteration of eEF-2 function has no effect on -1PRF 111-113, suggesting that post 
peptidyl transfer ribosomes cannot slip. In addition, protein sequencing of the 
frameshift products demonstrated incorporation of amino acids corresponding both to 
the 0 and -1 frames at the second codon of slippery site, which suggests that the 
identity of the amino acid at the A-site can be monitored (or aa-tRNA is selected) 
after tRNA slippage 114.  The peptidyl transfer presents 
 
                                               
iv All sequences in this thesis are given in the standard IUB/IUPAC amino acid and nucleic acid codes. 









Figure 1.12. -1PRF signal of HIV-1 virus 
The heptameric slippery site is separated from the pseudoknot by an eight nucleotide spacer. 







Figure 1.13. Simultaneous slippage model. 
An mRNA pseudoknot induces elongating ribosomes to pause with their A- and P-site tRNAs 
positioned over the heptameric N NNW WWH (G GGA AAC) slippery site (the 0-frame is indicated 
by spaces). The nature of the slippery site is such that if the ribosome shifts by 1 base in the 5' 
direction (red arrows), the non-wobble bases of both the A- and P-site tRNAs can re-pair with the 
new –1 frame codons. After slippage, the mRNA pseudoknot is eventually denatured, and elongation 
















 the point of no return in aminoacyl-tRNA selection, thus -1PRF is unlikely to occur 
after peptidyl transfer and therefore co-translocationally. To accommodate these 
findings, an “integrated model” has been proposed. This model is essentially the same 
as “simultaneous slippage model” but defines the timing of slippage. It suggests that 
-1PRF takes place prior to peptidyl transfer, probably during the aminoacyl-tRNA 
selection step 116.  
One of the main questions in the field is how mRNA pseudoknots promote 
efficient levels of –1PRF. Multiple studies demonstrated that a mRNA pseudoknot is 
essential for promoting efficient -1PRF. Disruption of the pseudoknot results in 
abolishing -1PRF 105,117. Substitution of the pseudoknot with a stem loop of similar 
size and stability also abrogated frameshifting 104. Notably, the -1PRF signal from 
HIV-1 initially identified as a stemloop was shown to form a pseudoknot, thus 
probably making the pseudoknot a ubiquitous requirement for efficient -1PRF and 
suggesting that the pseudoknot contains structural features that may be required for 
-1PRF. 
The “9Å solution” was proposed to explain how pseudoknots might trigger 
-1PRF. A major consideration of this model of –1PRF is that a pseudoknot has two 
regions with opposite 5' - 3' directionality. This, it makes the pseudoknot 
topologically more difficult to unravel in a linear fashion. In combination with poorly 
matched geometry between the pseudoknot and the ribosomal helicase, it may result 
in the pseudoknot blocking mRNA entry into the mRNA tunnel 115,118. Chemical 
toeprinting experiments detected: (A) Ribosomal pausing at the pseudoknot, (B) a one 




associated with transition of the aminoacyl tRNA from the A/T to the A/A state 
during accommodation. Thus, it was proposed, that accommodation may create 
tension in the mRNA between the decoding center of ribosome and the pseudoknot. 
The “9Å hypothesis” proposed that subsequent slip of mRNA in the 5’ direction 
relieves this tension resulting in -1PRF (Figure 1.14) 119.  
The 9Å model could be viewed as an extension of the “integrated model” 
described above. It places the -1PRF event at the aminoacyl tRNA selection step, 
before peptidyl transfer, thus accommodating the existing genetic and biochemical 
evidence.  
In contrast, several groups have proposed that slippage may occur co-
translocationally, and genetic and biochemical evidence suggested the importance of 
the P-site tRNA for -1PRF 120,121. Whether these observations explain when -1PRF 
occurs, or merely reflect the fact that -1PRF includes simultaneous slippage of both 
A- and P-site tRNAs remains to be answered. 
Programmed +1 Ribosomal Frameshifting 
Programmed +1 Ribosomal Frameshifting (+1PRF) is another example of a 
translational recoding event. +1PRF involves slippage of the translating ribosome by 
one nucleotide in the 3’ direction. Like Programmed -1 Ribosomal Frameshifting, 
+1PRF is also utilized by viruses and transposable elements to regulate the synthesis 
of structural and enzymatic proteins 122,123. Functional +1PRF signals also were found 










Figure 1.14. The 9-Å solution. 
A. The 0-frame A- and P-site codons of a programmed –1 ribosomal frameshift signal are base-
paired to cognate peptidyl- and aa-tRNAs occupying the P/P and A/T hybrid states respectively. B. 
Upon accommodation, the anticodon loop of the aa-tRNA moves 9 Å in the 5' direction, pulling the 
3' mRNA sequence along with it. The mRNA pseudoknot is too large to enter the downstream 
tunnel, with the consequence that the linker region between the A-site codon and the mRNA 
pseudoknot is stretched, creating a localized region of tension in the linker region of  mRNA. C. 
Decoupling of the A- and P-site codon-anticodon interactions from the 0-frame, and re-pairing in the 




The frameshifting mechanisms of all known +1PRF signals are conserved. 
Like -1PRF, the +1PRF signal contains a heptameric slippery site, albeit the nature of 
the slippery site is completely different. Also, a downstream secondary structure is 
not required for efficient +1PRF. Protein sequencing of +1 frameshift products 
demonstrated the unambiguous incorporation of the 0-frame amino acid at the first 
codon and +1 frame amino acid at the second codon of the slippery site. These 
observations suggest that +1PRF happens before peptidyl transfer at the second 
codon, probably before or during A-site aminoacyl-tRNA selection 128 
+1PRF is kinetically driven by the presence of a codon decoded by a low 
abundance tRNA (hungry codon) at the A-site. For example, the slippery site of the 
Ty1 retrotransposon is CUU AGG G (the incoming frame is indicated by spaces) 129. 
The 0-frame AGG codon is decoded by the scarce tRNAArg , while the +1 frame GGC 
codon is decoded by the highly abundant tRNAGly (Figure 1.15). The low abundance 
of the sense tRNA shifts the reaction of aminoacyl-tRNA selection toward the 
incorporation of a missense amino acid in the +1 frame. Amino acid starvation and 
genetic experiments support this hypothesis. Starvation by amino acid corresponding 
to the 0-frame codon induced +1PRF 130,131. In contrast, overexpression of the hungry 
codon tRNA 129 or substitution of the hungry codon to a codon decoded by the high 
abundant isoaceptor tRNA eliminated frameshifting 114,128. Thus from a kinetic point 
of view, the effects of the tRNA abundance could be seen as a type of kinetic 
partitioning 120. The shortage of the 0-frame A-site tRNA promotes ribosomal pause 






Figure 1.15. +1PRF. 
A "hungry" AGG codon in the 0-frame of the heptameric CUU AGG C slippery site (the incoming 
frame is indicated by spaces) causes elongating ribosomes to pause while awaiting delivery of the 
rare CCU-tRNAArg. Slippage of the ribosome by one base in the 3′ direction during this pause allows 
the P-site tRNA to base-pair to the +1-frame GGC codon, creating a new A-site codon that 












Figure 1.16. Kinetic model of +1PRF 
Different ribosomal complexes designated as RS0-3. Partial reactions are designated by the arabic 
numerals from 1 to 5. The changes in kinetic parameters that elevate rates of forward reactions (or 
decrease levels of the reverses reactions) in the left branch (and vice versa for the right branch) 
would elevate +1PRF level. For example, the rate of the 0-frame tRNA incorporation (1) is 
proportional would be proportional to the concentration of the RS0 complex and concentration of the 
cognate tRNA. The slippage (3) is a first order reaction with rate proportional to the concentration of 
the RS0 complex, and the rate constant. Thus abundance of the 0-frame tRNA would affect the ratio 
of reactions 1 and 3, in the agreement with observed effects of tRNA abundance on the +1PRF. It is 
obvious, that rate constant of the forward reaction (3) is determined by the stability of the codon 
anticodon duplex in the P-site of the RS0 complex, and rate constant of the reverse reaction (-3) 
would depend on the stability of the codon anticodon duplex in the +1 frame. Rapid recognition of 
the +1 codon after P-site tRNA slippage followed by the irreversible peptidyl transfer works as an 











recognition of the +1 frame codon by abundant tRNAs, followed by the peptidyl 
transfer prevents slippage back to the 0-frame (Figure 1.16). The rate of slippage 
would depend on stability of the P-site tRNA complex and abundance of the 0 and +1 
frame tRNAs. Also, in this model, the ratio of the 0-frame to the +1 frame aa-tRNA 
would determine the rate of the 0- and +1-frame recoding (reaction 1), thus defining 
the efficiency of frameshifting.  The high abundance of the +1frame tRNA is required 
to increase rate of the +1frame codon decoding thus locking the ribosome in the new 
frame through the irreversible peptidyl transfer (reactions 4 and 5).  
Several groups suggested that accommodation of +1 frame tRNA is preceded 
or accompanied by slippage of the P-site tRNA by one base prior incorporation of the 
A-site tRNA 120,132. Substitution of the P-site leucine codon in the Ty1 frameshift 
signal to any other leucine codon obliterated +1PRF frameshifting 87. This notion is 
also supported by the observation that slippery site sequences of multiple +1PRF 
signals (e.g. the Ty1 and Ty3 retrotransposons of S. cerevisiae, prfB release factor of 
E. coli and etc.) allow the P-site tRNA to form a codon-anticodon duplex in the +1 
frame. This notion is also supported by mutagenesis studies demonstrating that 
stability of the P-site interactions are critical for +1PRF efficiency 120,132. Kinetically, 
the stability of the P-site tRNA:ribosome interaction is the major determinant of the 
slippage efficiency, thus also determining the efficiency of frameshifting. 
Biological roles of the +1PRF and -1PRF 
Programmed ribosomal frameshifting is a conditional event that allows 
translation of a downstream reading frame with a certain probability. +1PRF and 




their enzymatic and structural proteins. The L-A virus and Ty1 retrotransposon of S. 
cerevisiae have long served as model systems for the studies -1PRF and +1PRF, 
respectively. 
The genome of the L-A virus encodes two open reading frames connected by 
a -1PRF signal. The first frame encodes the Gag (capsid) protein, and the second 
encodes a viral RNA dependent RNA polymerase (RDRP). -1PRF is required for 
RDRP expression, and frameshifting efficiency defines the ratio of the capsid protein 
to viral polymerase 105. Notably, viral polymerase is not only required for L-A 
replication and plus strand synthesis, but also nucleates capsid assembly. Alteration 
of frameshifting efficiency results in formation of incomplete viral particles, 
inhibiting L-A propagation 133. The L-A virus has a satellite called M1 that relies on 
L-A to supply capsid and RDRP. The single open reading frame of M1 encodes a 
protein toxin that is exported into the surrounding media and kills M1 minus cells, 
thus providing an easily detectable phenotype (Figure 1.17).  
Like retroviruses, Ty elements of yeast replicate via an RNA intermediate. 
The Ty1 frameshift signal connects two overlapping open reading frames (ORF) 
analogous to the retroviral gag and pol genes. Translation of the second frame (pol) is 
only possible as a result of +1PRF, which produces the gag-pol fusion protein 122,134. 
Frameshifting efficiency defines the ratio of gag and gag-pol, which is critical for 
successful retrotransposition. Throughout our studies, we used programmed 
ribosomal frameshifting as a functional tool to characterize ribosomal components 





















A few examples of frameshift signals have been found in genomes of higher 
eukaryotes, however their significance is less clear. The regulation of polyamine 
biosynthesis via +1PRF is the most well studied, and appears to be a universally 
conserved regulatory mechanism in higher organisms that utilizes +1PRF. Arginine is 
a common polyamine precursor. It is converted into agmatine by agmatine 
decarboxylase. Agmatine is then transformed to putrescine by agmatinase. 
Alternatively, in the predominant pathway, arginase degrades arginine into ornithine, 
which is then converted into putrescine by ornithine decarboxylase. Then putrescine 
is converted into spermidine and spermine in a cascade of subsequent reactions 
(Figure 1.18, reviewed in Childs A.C., et al 135).  
The conversion of ornithine to putrescine is the limiting step of this pathway. 
Remarkably, ornithine decarboxylase expression is regulated in a feedback loop by 
antizyme 136. The antizyme ORF is interrupted by a +1PRF signal, and translation of 
the downstream sequence is possible only as a result of +1PRF. Full length antizyme 
binds to ornithine decarboxylase and targets it for degradation by the 26S proteasome. 
The binding of antizyme also promotes dissociation of enzymatically active dimers of 
ornithine decarboxylase to enzymatically inactive monomers, resulting in a strong 
inhibition of ODC activity prior to degradation 137,138. Early studies demonstrated that 
+1PRF efficiency depends on polyamine concentrations. High concentrations of 
polyamines promote increased levels of +1PRF and thus elevating antizyme 
expression 139,140. This results in rapid degradation of ornithine decarboxylase and 
inhibition of the polyamine synthesis. 




















































genomes 107,110. These include the mouse mucin domain containing gene Muc1, the 
mouse embryonal carcinoma differentiation regulated Edr gene, it’s human 
orthologue PEG10, and the human paraneoplastic antigens Ma3 and Ma5. The 
presence of frameshifting product proteins in corresponding tissues has been 
demonstrated by western blotting and ability of these frameshift signals to promote 
-1PRF has been verified using artificial reporter systems. However, the functions of 
these genes and the significance of -1PRF signals remain unknown.   
A search of the S. cerevisiae genome performed in our lab revealed the 
presence of multiple -1PRF signals 106. Surprisingly, most of these signals do not 
direct the ribosome into new prolonged ORFs, but rather direct the ribosome to stop 
codons. Thus, -1PRF signals may act as conditional terminators of the protein 
synthesis, whose efficiency depends on frameshifting efficiency. It was proposed that 
the mRNA surveillance machinery would recognize such stop codons as premature 
termination codons, and that these mRNAs would be directed to degradation via the 
nonsense mediated decay (NMD) pathway. Thus -1PRF signals in eukaryotic 
genomes may work as mRNA destabilizing elements and therefore post 
transcriptionally regulate gene expression. This notion has been summarized in the 
“mRNA suicide” hypothesis 106,141. In line with this hypothesis, experiments with an 
artificial reporter system containing -1PRF signals in the middle of the PGK1 reporter 
gene demonstrated an inverse relationship between mRNA stability and -1PRF 
efficiency 141. Remarkably, microarray studies demonstrated that expression of 
approximately one third of the yeast genome is regulated via the NMD pathway 142-
144. It is currently unknown what fraction of these may be regulated via -1PRF. 




triggered by +1 frameshifting. There are currently no observations that may support 
or argue against involvement of +1PRF in regulation of mRNA stability.  
Nonsense mRNA Mediated Decay 
The nonsense mRNA mediated decay (NMD) pathway degrades mRNAs in 
response to the presence of premature termination codons (PTC). NMD requires 
ongoing translation, a set of ubiquitous factors, Upf1p, Upf2p and Upf3p, and a wide 
range of accessory proteins, including those involved in termination and mRNA 
degradation. The Upf proteins recognize the presence of premature termination codon 
in conjunction with termination factors, targeting PTC containing mRNAs for 
degradation. The mechanisms by which the Upf proteins distinguish premature from 
normal stop codons remains unclear, and may vary between different organisms. In 
mammalian cells, premature termination codons must be > 59 nucleotides upstream 
of the most 3' exon - exon junction to be recognized by the NMD pathway 145. In the 
nucleus, Upf3p interacts with the components of the splicesome and remains 
associated with mRNA after splicing and disassembly of the splicesome, thus 
marking the exon-exon junction 146,147. Interactions between the terminating ribosome 
and Upf3p is thought to recruit the other Upf proteins, promoting mRNA decapping 






X-ray crystal structures of the ribosome have greatly advanced our 
understanding of translation and provided positions and contacts of individual 
ribosomal components. These structures clearly demonstrated that ribosomes undergo 
multiple structural transitions during the elongation cycle. Currently, the dynamics of 
these transitions are still unknown. This work seeks to began to establish the 
connections between structure and function by identifying these components and 
uncovering the network of structural transitions that are responsible for information 
transfer between the active centers of the ribosome. Toward these ends, we used 
molecular genetics methods to identify functionally important residues in 5S rRNA 
and in ribosomal proteins L3 and L10. The mutants were characterized using genetic 
and biochemical methods. Chapter 2 discusses the role of ribosomal protein L3 in 
maintaining the conformation of the peptidyl transferase center and the aminoacyl-
tRNA accommodation route. Chapter 3 describes saturation mutagenesis of 5S rRNA. 
Analysis of naturally occurring allelic variants of 5S rRNA suggests that this 
molecule may be involved in post transcriptional regulation of cellular gene 
expression via -1PRF coupled with the nonsense mediated decay pathway. Chapter 4 
describes mutagenesis of ribosomal protein L10. The results of these experiments 
suggest that h38 and h89 participate in communication between the PTC and other 
active centers of the ribosome. Finally, Chapter 5 discusses these results in the 




Chapter 2.  Ribosomal protein L3 
Introduction 
Early in the history of modern yeast genetics, two mutants were independently 
identified based on separate phenotypes: resistance to the peptidyl transferase 
inhibitor trichodermin (tcm1-1) 149,150, and inability to maintain the M1 killer virus 
(mak8-1 = maintenance of killer) 151.  They were subsequently shown to be allelic to 
RPL3, the gene that encodes ribosomal protein L3, a 44 kDa essential large subunit 
ribosomal protein 152,153. Independently, ribosome reconstitution experiments 
demonstrated that L3 is one of a few proteins required for peptidyl transferase center 
(PTC) activity 154, and that L3 and L24 are the only two proteins capable of initiating 
in vitro assembly of the E. coli 50S ribosomal subunit 155,156. These early findings 
implicated L3 as a central component of peptidyl transfer activity, ribosome 
assembly, and as an important factor in the interaction between host cells and viruses. 
An initial study of the mak8-1 allele in the Dinman lab demonstrated that: (A) 
increased -1PRF efficiency constituted the basis for the loss of killer phenotype in 
mak8-1 cells; and (B) the original mak8-1 allele consisted of the double rpl3 mutation 
W255C+P257T 157. In a subsequent study, three additional single mutations were 
identified that were unable to maintain the killer virus (W255C, P257T, and I282T).  
The inability to propagate the killer virus in these strains was explained through 
elevated levels of -1PRF 158. Biochemical analyses demonstrated that increased 
efficiency of -1PRF correlated with reduced rates of peptidyl transfer 158. Importantly, 




specific to mak8-1: these two properties also correlated in mutants of ribosomal 
protein L41 (RPL41) and histone deacetylase (RPD3) 159,160. The molecular 
mechanism that couples -1PRF and peptidyl transferase activity is still unknown, 
however the existence of such a correlation suggests a functional link between -1PRF 
and peptidyl transfer.  
Notably, the initial screen for mutant alleles that affected frame maintenance 
resulted in identification of the mof6-1 allele of Rpd3. Expression of the mof6-1 allele 
promoted increased levels of the -1PRF and resulted in loss of the killer phenotype 
159,161. Rpd3p is a part of the large histone deacetylation complex that includes the 
DNA binding protein Sin3p, and the regulatory proteins Sap30p and Ume6p 162. 
Deacetylation of histones by Rpd3p promotes local chromatin condensation, resulting 
in repression of nearby PolII transcribed genes 163,164. Remarkably, mutations in the 
SIN3 and SAP30 components of this complex that promote chromatin condensation 
also resulted in increased levels of -1PRF 159,165. It is unclear how mutations in 
histone deacytelation complex promote the described phenotypes. One possibility is 
that these mutations may affect transcription of the ribosomal genes, including 
ribosomal proteins and rRNA. The resulting imbalance between ribosomal 
components may affect ribosomal biogenesis, resulting in formation of the 60S 
subunits that are different in their biochemical properties. However, the possibility of 
secondary effects has not been ruled out. The RPD3 complex regulates transcription 
of a wide range of genes. It is possible that mutations in the RPD3 complex may 
affect transcription levels of other components of the ribosome biogenesis machinery. 
Alternatively, the posttranscriptional regulation of mRNA stability via -1PRF and 




existence of trans-acting factors that specifically regulate -1PRF efficiency. The 
identities of these factors are currently unknown; however it is possible that the 
histone deacetylation complex may mediate expression of these factors. Regerdless, 
the possible link between ribosomal biogenesis and -1PRF is intriguing.  
Ribosomal protein L3 was also found to affect -1PRF. It contains two 
domains: a globular domain, located on the cytoplasmic side of the large ribosomal 
subunit, and a long extension that protrudes into the body of the large subunit toward 
the peptidyl transferase center. The globular domain of L3 forms extensive contacts 
with domain VI of 25S rRNA. It contacts h95 (at the tip of which is the sarcin-ricin 
loop (SRL)) and the GTPase associated center (h40-42). The base of the L3 extension 
interacts with the base of the h95.  The middle section of the extension comes into 
close contact with helix 40, (part of the GTPase associated center), and with helixes 
90, and 91. The distal portion of this domain contacts with the loop that connects 
helixes 89 and 90, and which forms the A-site region of the peptidyl transferase 
crevice. In the 3-D ribosomal structure, h95, h90-92, and h89 are stacked parallel to 
one another and form a continuous rRNA layer 166,167 (Figure 2.1). The mak8-1 
mutations are located in the tip of the extension, and tryptophan and proline residues 
contact with the loop that connects helixes 89 and 90. Notably, mutations in the same 
vicinity of the L3 proteins of E. coli and Brachyspira spp. also promoted resistance to 













Figure 2.1. Position and contacts of ribosomal protein L3. 
Ribosomal protein L3 contacts with the sarcin-ricin loop (SRL), the GTPase associated center (h40), 
helix 89, helixes 90-92, and helix 95 of 25S rRNA. The tip of the extension domain interacts with 
the peptidyl transferase center. (Based on the Cryo-EM structure of the S. cerevisiae ribosomes from 





 of peptidyl transfer 168, thus suggesting necessity of this domain for proper ribosomal 
function. Notably, previous studies in the Dinman lab demonstrated effects of 
peptidyl transferase inhibitors on the efficiency of -1PRF, thus linking peptidyl 
transfer and translational recoding 160,169. Biochemical characterization of rpl3 mutant 
strains showed altered levels of peptidyl transfer and -1PRF in these strains. These 
observations provoked more in-depth characterization of the mak8-1 mutants. Toward 
this end, characterization of existing mutant alleles of L3 was conducted. Strains 
harboring mutant alleles of ribosomal protein L3 were characterized for their effects 
on cell propagation, protein synthesis and biochemical properties of mutant 
ribosomes. We found that mutations in L3 affected resistance to the peptidyl 
transferase inhibitors anisomycin and sparsomycin. Biochemical characterization 
demonstrated: (A) that elevated affinity for A-site tRNA is the underlying cause of 
anisomycin resistance in L3 mutants; (B) a correlation between increased affinity for 
aminoacyl-tRNA and elevated levels of -1PRF; (C) conformational changes in the 
vicinity of the PTC; and (D) altered DMS reactivity of the bases that form the "gates" 
through which the aminoacyl-tRNA passes during accommodation. These findings 
implicate ribosomal protein L3 in maintenance of the conformation the peptidyl 
transferase center and of the tRNA accommodation route. 
Materials and methods. 
Strains, media and genetic methods.  
E. coli strain DH5α was used to amplify plasmid DNA. Protocols for 
transformation of yeast and E.coli and the YPAD, synthetic drop out medium (H-), 




reported 170,171. Strains used in this study are listed in the Appendix A, page 160. 
Doubling times were determined by fitting exponential sections of the growth curves 




0= , where y is the OD595, t is time and T is the doubling time. 
Drug sensitivities toward anisomycin and sparsomycin (Figure 2.2) were determined 
by dilution spot assays. Logarithmic dilutions starting from 105 CFU were spotted on 
plates with or without drug. Then plates were incubated at 30 °C for 3 days. The 
qualitative score was assigned by comparing the growth of mutant and wild type 
strains on media with and without the each drug. Positive scores were assigned to 
resistant strains and negative to sensitive strains.  
In vivo methionine incorporation 
In vivo methionine incorporation experiments to determine the rates of the 
protein synthesis were performed as described previously 172. Briefly, 100 ml cell 
cultures were grown in media lacking methionine to an OD595 of 0.5-0.7. Then 5 
µMoles of unlabeled methionine and 100 µCi of 35S labeled methionine were added, 
resulting in a final specific activity of 20 mCi/mmole, and a concentration of 1 
µCi/ml. Two 1 ml aliquots were collected every 10 minutes. The first aliquot was 
used for obtaining OD595 readings; and 200 µl of 50 % TCA was added to the second 
aliquot. The samples were incubated on ice for 20 minutes and then at 70 °C for 20 
minutes. The samples were applied to GF-C glass filters, and filters were washed 

































 scintillation counting. All time points were taken in triplicate. The obtained cpm 
counts were normalized by amount of cells in each sample measured as OD595 at each 
time point and plotted versus time. The rates of protein synthesis were calculated as 
the slope of the linear regression trendlines and expressed as counts per minute per 1 
OU at 595 nm.  
In vivo methylation of rRNA adenosines 
Unprotected adenosine bases in yeast rRNA were methylated in living cells with 
dimethylsulfate (DMS) using a modification of a previously described method 173. 
Logarithmically growing yeast cells (10 ml, OD595 between 0.5 and 1.0) were pelleted 
by centrifugation, resuspended in 0.5ml of growth media, then DMS was added to 
concentrations of either 80 mM or 160 mM, and samples were incubated at room 
temperature for 2 minutes. Reactions were arrested by addition of ice cold β-
mercaptoethanol to a final concentration of 0.7 M and 0.25 ml of ice cold water 
saturated with isoamyl alcohol. Control cells were not treated with DMS. Total 
nucleic acids were extracted by the Smash and Grab method described below. 
Reverse transcription reactions were performed at 45 ºC using 10 µg of rRNA, [32P]-
labeled oligonucleotides, and AMV reverse transcriptase (Roche). Strong stops one 
nucleotide 5' of modified bases were visualized by separating the reaction mixes 


















 Total RNA extraction (Smash and Grab) 
Yeast cells (up to 50 O.U. at 595 nm) were suspended in 400 µl "Smash & 
Grab" buffer (10 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 1 % SDS, 2 % 
Triton X-100). Then one half volume of 0.5 mm glass beads and 400 µl Acid-
Phenol/Chloroform (5:1, pH 4.9) were added to the cells.  Nucleic acids were 
extracted by vortexing for 2 minutes, and debris was removed by centrifuged for 15 
minutes at 14,000 rpm. The aqueous phase was collected and re-extracted with 400 µl 
Acid-Phenol/Chloroform.  The extraction was performed one more time with Acid-
Phenol/Chloroform and one time with Chloroform. The aqueous phase was collected 
and nucleic acids were precipitated by additing 0.1 volumes of 3 M Na(CH3COO) pH 
5.2 and 2.5 volumes of 95 % ethanol. The nucleic acids were precipitated by 
incubating at -70 ºC for 30 minutes, and subsequent centrifugation for 15 minutes. 
Then, RNA pellets were washed with 1 ml 70 % ethanol, dried, and resuspended in 
50 µl DEPC treated H2O. 
Purification of aa-synthetases 
Aminoacyl-tRNA synthetases were purified as previously described with 
minor modifications 174. Two pounds of frozen cake yeast (George R. Ruhl & Son, 
Inc., Hanover, MD) were placed in 500 ml of buffer A [0.2 M Tris-base, 0.3 M 
NH4Cl, 20 mM MgSO4, 1 mM EDTA, 0.15 M dextrose] and allowed to thaw and 
ferment overnight. Cells were disrupted by three passages through an ice-cooled 
Microfluidaser at ~18,000 lb/in2, cell debris was removed by centrifugation at 4 °C in 
a Beckman JLA rotor at 10,000 rpm for 30 minutes, and 800 ml of supernatant was 




(1.73 g/lb of cells, equivalent to 4.32 g/liter of lysate) over a period of 5 minutes with 
slow stirring. Precipitates were removed by centrifugation at 4 °C using a GSA rotor 
at 9,000 rpm for 40 minutes. Proteins in the supernatant were precipitated by addition 
of 472 g of ammonium sulfate per liter of extract (70 % saturation), and precipitates 
were collected by centrifugation in a GSA rotor at 12,000 rpm for 45 minutes at room 
temperature. The pellet from this step was suspended in 43.75 ml of buffer C [30 mM 
potassium phosphate, pH 7.2, 1 mM EDTA, 1 mM DTE, 0.01 mM PMSF] per 100 g 
of pellet and subsequently dialyzed in 2 liters of buffer C overnight with two changes 
of buffer. The extract then was clarified by centrifugation in a GSA rotor at 12,000 
rpm for 45 minutes at 4 °C. The supernatant was diluted 2.5 times with buffer C and 
fractionated through a Sephadex CM50 column equilibrated with buffer C. The 
column was washed with buffer D [30 mM potassium phosphate, pH 7.2, 1 mM 
EDTA, 0.01 mM PMSF, 10 % glycerol] with 50 mM KCl. The proteins were eluted 
from the column using a series of step gradients composed of buffer D containing 150 
mM, 300 mM, and 500 mM KCl. The material eluted by buffer D with 150 mM KCl 
contains phenylalanyl-tRNA synthetase activity. Proteins were precipitated by 
addition of 472 g/liter of ammonium sulfate, and pellets were suspended in buffer D 
containing 50 mM KCl. Extracts were dialyzed against 1 liter with two changes of 
buffer D50 for 10 h, after which they were clarified by centrifugation in a GSA rotor 
at 12,000 rpm for 45 minutes at 4 °C. The obtained preparations of aa-tRNA 




Synthesis of aa-tRNA and Ac-aa-tRNA and HPLC purification 
Yeast phenylalanyl-tRNAs were aminoacylated by scaling up a previously 
described method 175. The reaction mix (5 ml) contained 300 mM Tris-HCl, pH 7.6, 
100 mM KCl, 20 mM MgCl2, 0.4 mM ATP, 40 µM [14C]Phe [496 mCi/mmole], plus 
5 mg of tRNA-Phe and 475 µl of aminoacyl-tRNA synthetases (D150) purified as 
described above. Reaction mixtures were incubated for 30 minutes at 30 °C, and 
proteins were removed by extraction with acid-phenol-chloroform. [14C]Phe-tRNA 
was separated from uncharged tRNA and free [14C]Phe by high-performance liquid 
chromatography (HPLC) as previously described 176 with the following 
modifications. Samples were loaded onto a 4.6x250 mm JT Baker wide-pore butyl 
column equilibrated with buffer A [20 mM NH4(CH3COO), 10 mM MgCl2, 400 mM 
NaCl; pH 5.0] at 1 ml/min. The column was washed with 10 ml of buffer A, creating 
conditions under which free phenylalanine and aminoacyladenylate are eluted from 
the column. Uncharged tRNAs were eluted by isocratic elution with 19 ml at 15 % of 
buffer B [20 mM NH4(CH3COOH), 10 mM MgCl2, 400 mM NaCl, 60 % methanol; 
pH 5.0). [14C]Phe-tRNA was eluted using a step gradient to 100 % of buffer B. 
Elution of aminoacyl-tRNA was monitored by OD260/280 readings, and [14C]Phe-
tRNA peak and concentrations were determined by scintillation counting. The 
presence of aminoacyl-tRNA in the eluted material was confirmed by gel filtration 
through G-25 spin columns and by nonenzymatic hydrolysis of ester bonds at basic 
pH 177. Ac-[14C]tRNA was obtained in a similar manner. Yeast phenylalanyl tRNA 
was charged with [14C]Phe as above and extracted with phenol. The [14C]Phe-tRNA 




on ice 176. The reaction mix was clarified by centrifugation at 15,000 rpm for 3 
minutes, and Ac-[14C]Phe-tRNA was purified by HPLC as described above. 
Isolation of ribosomes  
Yeast ribosomes were isolated using a modification of a previously published 
protocol 176. Briefly, cells were grown in YPAD medium to an OD595 of 0.8, collected 
by centrifugation, and washed twice with cold 120 mM KCl. Cells were suspended to 
concentrations of 1 g/ml in buffer A [20 mM Tris-HCl, pH 7.5 at 4 °C, 5 mM 
Mg(CH3COO)2, 50 mM KCl, 10 % glycerol, 1 mM PMSF, 1 mM DTE], and one-half 
volume of glass beads (0.5 mm) were added. Then cells were disrupted at 4 °C with a 
Mini BeadBeater for 2 minutes at maximum speed. Extracts were transferred to 4ml 
centrifuge tubes, and glass beads were washed twice with 1 ml of buffer A. Washes 
were combined with extracts and spun in an MSL-50 rotor (Beckman) for 25 minutes 
at 20,000 rpm. Supernatants were transferred to 4 ml polycarbonate tubes containing 
1 ml of a cushion of buffer B [20 mM Tris-HCl, pH 7.5 at 4 °C, 5 mM 
Mg(CH3COO)2, 50 mM KCl, 25 % glycerol, 1 mM PMSF, 1 mM DTE], and 
ribosomes were sedimented by centrifugation at 4 °C for 2 h at 50,000 rpm using the 
MSL-50 rotor. Fines from ribosome pellets were gently washed off with buffer C [50 
mM Tris-HCl, pH 7.5 at 4 °C, 5 mM Mg(CH3COO)2, 50 mM NH4Cl, 0.1 mM PMSF, 
0.1 mM DTE, 25 % glycerol]. Ribosomes were suspended in buffer C at 
concentrations of 2 to 10 pmol/µl (1 OD260 = 20 pmol) and stored frozen at –80 °C. 
tRNA binding 
The tRNA binding assay is based mainly on the work of Nierhaus and Synetos 




rules of tRNA binding to the ribosome. tRNA binding can be predicted based on the 
nature of the tRNA and ribosomal state during the tRNA binding reaction. These 
rules are summarized in the Figure 2.4 178. 
Ac-Phe-tRNA was used as a substrate in the P-site binding assay. Acetylation 
of the primary amino group of phenylalanine mimics the peptide bond, and the 
ribosome recognizes this substrate as a peptidyl-tRNA 176,179.  Thus, according to the 
rules (Figure 2.4), this substrate would directly bind to the P-site of the empty 
ribosomes. The A-site binding assay starts with pre-incubation of the ribosomes with 
poly U and an excess of deacylated tRNA. Deacylated tRNA first occupies the P-site 
of the ribosome, and then fills the E-site, thus resulting in formation of the poly U 
charged ribosomes with pre-occupied P and E sites (Figure 2.4). Following the tRNA 
binding rules, the aminoacyl-tRNA binds to the A-site of this complex (Figure 2.4, P 
and E-sites are occupied). Early studies of translational apparatus demonstrated that 
eEF-1 co-purifies with non salt washed ribosomes. During the binding reaction, Phe-
tRNA forms the ternary complex eEF-1:GTP:Phe-tRNA, which subsequently binds to 
the A-site. The joint efforts of two groups demonstrated that eEF-1 is present in 
excess in preparations of the non salt washed ribosomes, and that eEF-1 does not 
limit tRNA binding or peptidyl transfer (which involves aa-tRNA binding as a partial 
reaction) 176,180,181. 
The assays were performed at equilibrium, as was determined by the time 
dependence of tRNA binding. Aminoacyl-tRNA binding to the A-site of the ribosome 
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80 mM Tris-HCl, pH 7.4, 160 mM NH4Cl, 11 mM Mg(CH3COO)2, 6 mM β-
mercaptoethanol, 0.4 mM GTP, and 2 mM spermidine, 0.4 µg/ml of poly(U), and 12 - 
25 pmol of ribosomes. The reaction mixtures were preincubated with uncharged 
tRNA (4:1 tRNA/ribosomes) at 30 °C for 15 minutes to ensure full occupation of P- 
and E-sites by uncharged tRNA, after which various quantities (4 – 264 pmol) of 
[14C]Phe-tRNA or Ac-[14C]Phe-tRNA were added. Reaction mixtures were incubated 
at 30 °C for an additional 20 minutes to allow formation of [14C]Phe-tRNA-80S-
poly(U) complexes. Aliquots were then applied to nitrocellulose membranes, filters 
were washed with 2 ml of binding buffer, and radioactivity was measured by 
scintillation counting. Background levels of radioactivity were determined using a 
blank sample and subtracted from the test samples. Acetyl-aminoacyl-tRNA binding 
assays were performed in a similar way, but deacylated tRNA was omitted from pre-
incubation mix. 
Data analysis 
Data obtained in the tRNA binding experiments were plotted onto Scatchard 





]/[][ 0RSRStRNAv •=  and represents the number of bound tRNA molecules per 
ribosome, [tRNA] is the concentration of unbound tRNA, and aK  is the apparent 
association constant. The plot v  vs. ]/[tRNAv  represents a straight line and provides 
aK as the negative slope. Plots for different mutants were normalized to the 
percentage of active ribosomes in each preparation, and aK  values were determined 




Computational analysis of the ribosome structure.  
Cryo-electron microscopy (cryo-EM) reconstruction of Saccharomyces 
cerevisiae ribosomal proteins threaded onto the X-ray crystal structure of the H. 
marismortui 50S ribosomal subunit 184 was visualized using Pymol 185. 
Results 
Expression of mutant forms of L3 affects rates of cell growth, protein synthesis 
and antibiotic resistance. 
In an effort to understand the consequences of expressing mutant forms of L3 
on cell growth and division, RPL3::HIS3 gene knockout strains harboring plasmid-
borne wild-type or mutant alleles of rpl3 were inoculated into standard defined 
medium lacking tryptophan (H-trp) to OD550 ~0.01, and growth rates were 
determined by measuring optical densities of aliquots taken at 1h intervals. The 
growth curves are shown in Figure 2.5. The results demonstrated that the I282T 
mutant had the least effect on cell doubling times (~110 min, compared to ~92 min 
for cells expressing the wild type gene, see Figure 2.5, Figure 2.6 and Table 1). More 
significantly, expression of the peptidyl transferase center-proximal mutants, i.e., 
W255C, P257T, and mak8-1 (W255C + P257T) had dramatic effects on cell growth 
rates (doubling times of ~150 min, ~130 min and ~155 min respectively, Table 1 and 
Figure 2.6). 
As the gene in question encodes a ribosomal protein, we assayed the effects of 
the mutations on protein synthesis by examining rates of [35S]methionine 




























































Figure 2.5. Growth curves and rates of protein synthesis of L3 mutants. 
Plasmid-borne alleles of RPL3 were expressed in isogenic RPL3::HIS3 gene disruption 
backgrounds. Growth curves and rates of methionine incorporation were measured as described in 
the Materials and methods (page 50). Exponential trendlines for logarifmic parts of the growth 



























Strain y 0 a (ln2/T), h
-1 R2
WT 0.0179 0.4515 0.9986
mak 8-1 0.0124 0.2687 0.9834
P257T 0.0116 0.3165 0.9846
I282T 0.0146 0.3850 0.9973






Figure 2.6. Doubling time calculations 
Panel A shows the exponential regression trendlines according to the equation axeyy 0= . The 
obtained trendline parameters (B) have been used to calculate doubling time according to the 
equation: 
T





  WT G15C P18S I282T P257T W255C mak8-1 
Dbl. time, min 92 - - 110 130 150 155 
Prot. syn, 
cpm/min. 10331 - - 8196 7233 6118 5762 
Anisomycin 0 0 +3 +2 +2 +4 +4 
Ka for aa-tRNA 
to the A-site  
(x106  M-1) 
1.1 7.1 4.3 - - 7.3 - 
Sparsomycin 0 - - 0 -2 -2 -2 
Ka for 
peptidyl-tRNA to 
the P-site  
(x106  M-1) 
< 0.9 - - < 2.4 7.9 3.7 9.8 
Pep-transferase 
158 WT - - ‚ ‚‚ ‚‚‚ ‚‚‚ 
-1PRF, % 158,182 8.8 14.4 - 13.2 13.9 14.2 14.5 
 
Table 1. Summary of properties of rpl3 mutants 
Doubling times were calculated as described in Materials and methods (page 49). The rates of 
protein synthesis were calculated as a slope of the linear regression trendlines and expressed as cpm 
per minute per 1 OD of the cells at 595 nm (page 50). Drug sensitivities were assessed by dilutions 
spot assay and quantitative scores were assigned. Positive scores correspond to resistant and negative 
scores to sensitive phenotypes. The aminoacyl-tRNA affinities were measured as described in 
Materials and methods (page 57). -1PRF efficiencies are from Meskauskas A., et al 182, and 
Meskauskas A., et al 158. The rates of the peptidyl transfer (Pep-transferase are cited from 





experiments are shown in Figure 2.5 and Table 1. The results indicate that, with 
respect to protein synthesis, the mutants exhibited a pattern similar to those observed 
with regard to growth rates, i.e., WT > I282T > P257T > W255C > mak8-1 
(10331,8196,7233,6118, and 5762 cpm/min/OU595 correspondingly). 
To reveal effects of the L3 mutant alleles on ribosomal function, a 
pharmacogenetic approach was employed. Strains were tested for 
resistance/hypersensitivity to two peptidyl transferase inhibitors, anisomycin and 
sparsomycin. Anisomycin is a competitive inhibitor of the peptidyl transferase 
reaction and interferes with binding of A-site substrate. It binds in the vicinity of the 
peptidyl transferase center, and the p-methoxyphenyl group of anisomycin fills the 
hydrophobic crevice normally occupied by the peptidyl moiety of aminoacyl-tRNA 
(Figure 2.7) 186. We found that, mutant L3 alleles promoted resistance to anisomycin. 
The mak8-1 and W255C alleles showed maximum resistance and were assigned a 
score of +4 (see Materials and methods page 49, and Figure 2.8). Sparsomycin is a 
peptidyl transferase inhibitor that mostly affects the P-site. It requires a P-site 
substrate for stable interaction with the ribosome, and does not binds to the ribosomes 
in the absence of a peptidyl-tRNA 187. The pyrimidine ring of sparsomycin is 
sandwiched between the CCA end of the P-site tRNA and helix 91 of 25S 
rRNA.(A2637 in H. marismortui Figure 2.9). The tail of the molecule is pointed 
toward the active site crevice and partially occupies the aminoacyl-tRNA binding 
pocket (Figure 2.7) 186. Three strains (mak8-1, W255C and P257T) were 















Figure 2.7. Anisomycin and sparsomycin binding sites. 
Anisomycin and sparsomycin bind at the peptidyl transferase center. The bases that interact with 
drug molecules are shown as the red stick models. The amino acid residues W255 and P257 of 










YPAD Anisomycin 25µg/ml Sparsomycin 35µg/ml
 
Figure 2.8. Strains containing mutant forms of L3 have altered drug sensitivity phenotypes. 
Mid-log phase cultures of isogenic strains harboring various plasmid-borne RPL3 alleles were 
spotted in 10-fold dilutions onto YPAD alone (No Drug), YPAD containing anisomycin (25µg/ml), 





Figure 2.9. Interactions of sparsomycin with the P-site substrate 
The sparsomycin ring is sandwiched between C75 and A76 of the P-site tRNA, and A2637 (H. 
marismortui). The tail of the molecule is pointed toward the A-site crevice. Modified from Hansen 




Mutant forms of L3 promote increased ribosome affinities for tRNAs 
Observations that mutations in ribosomal protein L3 affect sensitivity to 
peptidyl transferase specific drugs suggest that these mutations may affect how 
ribosomes functionally interact with tRNAs. To test this hypothesis, filter binding 
assays were used to monitor the affinities of wild-type and mutant ribosomes for 
tRNAs using [14C]Phe–tRNAPhe and [14C]Ac-Phe–tRNAPhe, which have been 
previously demonstrated to bind exclusively to the A- and P-sites respectively 188.  An 
inherent complication in the biochemical comparison of different samples is that 
specific activities of the samples vary from preparation to preparation. Thus, the 
absolute amounts of bound tRNA are not directly comparable between samples, and 
do not reflect affinity of the tRNA to ribosomes. The widespread error in analysis of 
tRNA-ribosome interactions derives from the fact that yield activities of samples have 
not been controlled, and tRNA affinities have been described as amounts of bound 
tRNA at the single substrate concentration 189-191. To overcome this problem, 
experiments were conducted over a range of tRNA concentrations and Ka values 
were calculated by Scatchard plot analysis. Peptidyl-tRNA binding analysis 
demonstrated that the sparsomycin sensitive mutant ribosomes generally have higher 
affinities for Ac-Phe–tRNAPhe (Figure 2.10). These results are in agreement with the 
previous suggestion that elevated affinity of the P-site for tRNA aggravates the effect 
of sparsomycin 192. The effects of P-site tRNA affinity on sparsomycin sensitivity 
could be explained by a mechanism of inhibition of the peptidyl transferase by 






Figure 2.10. Characterization affinities for aa-tRNAs and peptidyl-tRNA by wild-type and 
mutant ribosomes. 
Ribosomes isolated from yeast cells expressing the wild-type, G15, P18S, W255C, P257T, I282T, 
and mak8-1 mutant forms of L3 were used for assays.  tRNA binding was carried out as described in 
Materials and methods (page 57). Data were plotted onto Scatchard plot and Ka values were 
determined as the slopes of linear regression trendlines. The A-site binding data was normalized to 
the amount of active ribosomes determined as the intersection with the abscissa axis on the initial 
Scatchard plot. The P-site binding data was not normalized to illustrate amount of the active 
ribosomes.  































































































requires a P-site substrate for efficient binding. During the elongation cycle, the P-site 
is always occupied either by peptidyl-tRNA or deacylated tRNA. However, the 
flexibility of the acceptor end of the P-site tRNA may influence the ability of 
sparsomycin to interact with the ribosome by affecting the number of the possible 
conformations, or half-lives of the ribosome conformations to which sparsomycin 
may bind. While no direct data describing dynamics of the P-site tRNA are available, 
we hypothesize that the L3 mutants may stiffen the acceptor end of the P-site tRNA 
(which translates in increased [Ac]Phe-tRNA affinity), thus promoting formation of 
the sparsomycin:ribosome complex.  
To reveal the functionally important groups of ribosomal protein L3, a library 
of randomly generated rpl3 alleles was screened for resistance to anisomycin, 
resulting in the identification of 43 new rpl3 alleles 182.  Since anisomycin prevents 
binding of aa-tRNAs 193,194, mutants resistant to this drug might be expected to have 
increased affinities for aa-tRNAs.  To test this model, aa-tRNA binding affinities to 
the A-site were determined for ribosomes purified from a few selected strains 
identified in the prior screens for anisomycin resistance and loss of the killer 
phenotype, taking care to block non-specific binding to ribosomal P- and E- sites by 
pre-incubating ribosomes with uncharged tRNAs.  The results of these experiments 
are represented in the form of a Scatchard plot in Figure 2.10, and summarized in 
Table 1.  This analysis reveals that Ka’s of wild-type, G15C, P18S, and W255C 
ribosomes for aa-tRNAs are 1.1x106 M-1, 7.1x106 M-1, 4.3x106 M-1 and 7.3x106 M-1 
respectively.  Thus, as predicted, the anisomycin resistant strains have increased A-




The mak8-1 form of L3 has an effect on the structure of the large subunit rRNA. 
The observation that ribosomes containing mutant forms of L3 had decreased 
peptidyl transferase activities 158 was suggestive of an underlying structural defect. To 
test this hypothesis, the effects of the mak8-1 form of the protein on the structure of 
25S rRNA were probed in vivo by treating cells with the RNA methylating agent 
DMS. In this method, unpaired adenine and cytosine bases are the most reactive and 
are typically most sensitive to structural changes  195,196. Modification by DMS is 
detected as strong stops in reverse transcriptase primer extension assays one 
nucleotide 5’ of the site of methylation. Primers 25-4, 25-6, and 25-7 (see Appendix 
C and Table 11) were used to determine the methylation patterns of 25S rRNAs from 
isogenic strains expressing wild-type L3 or mak8-1 through an approximately 400 
nucleotide stretch of domain V, comprising 25S rRNA nucleotides positions 2650 to 
3040. The results show that expression of the mak8-1 form of L3 affects the structure 
of the 25S rRNA in a number of discrete regions. In particular, nucleotides in the loop 
region of helix 85 (A2690–A2704) were better protected from DMS attack in mak8-1 
ribosomes relative to wild-type (Figure 2.11 and Figure 2.12). Though the enhanced 
protection of these residues in mak8-1 ribosomes was modest, this pattern was 
observed in every repetition of this experiment. We suggest that the reason for the 
weak pattern of enhanced protection originates from the in vivo nature of the assay 
which probes all of the ribosomes in the cell in every different stage of elongation; 
each of these has a different status with regard to interactions with elongation factors 






Figure 2.11. The mak8-1 form of L3 affects the structure of the 25S rRNA.  
Isogenic wild-type (RPL3) and mak8-1 cells were treated with DMS in vivo. Reverse transcriptase 
extensions of [32P]-labeled primers were performed using extracted rRNAs as templates, the 
reactions were separated through 6 % urea-polyacrylamide denaturing gels, and visualized by 
autoradiography.  Autoradiograms of the primer extension reactions using Oligo 25-4 and Oligo 25-
7 are shown. Sequencing ladders are reverse labeled so as to reflect the sense strand of 25S rRNA in 
the indicated 5’ to 3’ directions. DMS concentrations are shown in mM. Specific protected or 
deprotected bases are indicated. 
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Figure 2.12. Position of L3 mutants in the ternary ribosomal structure. 
The yeast ribosomal rRNA and proteins were modeled in the context of the crystal structure of H. 
marismortui ribosome. The body of L3 is located on the surface side of the large subunit, while the 
tip of the protein protrudes toward the peptidyl transferase center. The A site substrate is depicted in 
yellow and the P site substrate is in brown. The residues that exhibit altered DMS reactivity in mak8-




difference is due to altered interaction of mak8-1 ribosomes with another factor, most 
likely the T-loop of the peptidyl-tRNA, which has been shown to interact with the 
loop region of helix 85 in the T. thermophilus large subunit 44. This finding is in 
agreement with observed correlation between increased affinities for peptidyl-tRNA 
and sparsomycin sensitivity, which suggests that altered interactions between the P-
site tRNA and ribosome is the underlying cause of drug phenotypes. In contrast, 
expression of the mak8-1 form of L3 resulted in strongly enhanced deprotection 
patterns of specific bases in helices 89, 90 and 91, suggesting intrinsic differences in 
ribosomal structure (Figure 2.12). For example, A2844 in the distal loop of helix 89 
became accessible to DMS modification. A similar pattern in the proximal arm and 
distal loop in helix 91 appears to render A2891 and A2910 hypersensitive to 
methylation by DMS. Hypermethylation was observed at position G2921 in the A-
loop, the E. coli counterpart of which (G2554) is a cross-link site to a puromycin 
derivative 197. Moderate levels of deprotection were also observed at positions A2951 
(the analogous E. coli U2584 is a footprint site for P-site tRNA 197), and the naturally 
methylated C2958. For unknown reasons, the strong reproducible stop at A2945 
disappeared at higher DMS concentrations. This pattern was observed reproducibly 
observed in the in vivo DMS modification experiments with these strains, but has not 
been found in in vitro structure probing experiments conducted in our laboratory. 
These results may be due to probing of multiple conformations of the ribosomes in 
vivo, and (or) from effects of DMS modifications on RNA stability in the subsequent 
extraction step. However, regardless of the possible origin of this stop, since it 
occurred in both wild-type and mak8-1 samples, it is probably not informative in 





Although accumulating evidence indicates that rRNA is the main, and perhaps 
only, catalytic component of the ribosome, mutational analysis has long ascribed 
significant functional relevance to several ribosomal proteins 198-201. The effects of 
expression of RPL3 mutants on tRNA binding, resistance to PTC specific translation 
inhibitors and structural changes indicate that L3 belongs to this class of ribosomal 
proteins. The questions are whether the functional effects of the mutations 
characterized in this study are due to changes in rRNA structure conferred by the 
mutant proteins, or might L3 be directly involved in structural transitions during the 
elongation cycle? To address this, a new characterization of existing L3 mutants was 
conducted. We found that mutations in ribosomal protein L3 affect resistance to the 
peptidyl transferase inhibitors anisomycin and sparsomycin. There are several 
explanations for how mutations in L3 can result in anisomycin resistant and 
sparsomycin sensitive phenotypes. First, drug resistance or sensitivity may arise from 
decreased affinity of the inhibitor-ribosome interaction. This mechanism of resistance 
toward peptidyl transfer inhibitors was previously observed for tiamulin and 
avilamycin 168,202. Examination of the X-ray crystal structure of the H. marismortui 
large subunit shows that two of the anisomycin resistant mutants, W255C and P257T, 
are located close to the peptidyl transferase center (Figure 2.12) and thus may directly 
affect PTC conformation and drug resistance. rRNA structure probing of mak8-1 
ribosomes confirms this notion demonstrating that A2951 (PTC, in S. cerevisiae, E. 
coli 2585) is deprotected in the mak8-1 strain. Remarkably, it has been previously 
demonstrated that lack of post transcriptional modification of this base affects the 




ribosomes complexed with sparsomycin demonstrated that U2584 and U2585 (in E. 
coli, S. cerevisiae bases U2952 and U2953) are part of the sparsomycin binding 
pocket. In vitro structure probing experiments of W255C strain with CMCT 
conducted in our group also demonstrated protection of one of those residues - U2953 
in the mutant strain 204. Thus these results suggest that L3 mutants promote an altered 
conformation of the PTC. 
Our observations suggest a role for L3 and (or) L3 contacting elements in 
activation of the peptidyl transferase center. The induced fit hypothesis of PTC 
activation suggests that movements of bases in positions 2583–2585 (in E. coli, S. 
cerevisiae 2951-2953) and U2506 (in E. coli, S. cerevisiae U2874) serves to 
reorganize the geometry of the PTC and make the ester group of the peptidyl-tRNA 
accessible for nucleophilic attack 39.When the PTC is in the "uninduced" (non-active) 
state, U2585 (in E. coli, S. cerevisiae U2953) is buried inside of the ribosome, and its 
Watson-Crick face is protected by U2506 (in E. coli, S. cerevisiae U2874). A2583 (in 
E. coli, S. cerevisiae A2951) stacks with U2584 (in E. coli, S. cerevisiae U2952), and 
A2583 is available for modification. Upon transition to the active state, U2506 (in E. 
coli, S. cerevisiae U2874) moves toward the P-site, exposing the Watson-Crick face 
U2585 (in E. coli, S. cerevisiae U2953) making this base accessible for modification. 
The observed mild hypermethylation of A2951 may result from the distorted position 
of U2874 (in S. cerevisiae), which partially shields the Watson-Crick face of A2951 
(in S. cerevisiae) in the "uninduced" conformation. We hypothesize that mutations in 
L3 promote the "uninduced" PTC conformation and impede the transition into the 








Figure 2.13. Conformational transitions in the PTC associated with adoption of the induced 
conformation.  





defects of W255C, P257T, and mak8-1 ribosomes in the puromycin reaction (Table 
1) 158. Puromycin fails to trigger the "active" conformation, and rates of peptidyl 
transfer with puromycin are a few orders of magnitude lower than with native aa-
tRNA. Thus, the puromycin reaction likely occurs as a result of spontaneous 
activation of the PTC due to random sampling of conformations by the ribosome. The 
stiffened conformations of U2506, U2584 and U2585 (in E. coli, S. cerevisiae U2874, 
U2952 and U2953) in the uniduced state, i.e. in the L3 mutants, would encumber 
these oscillations resulting in a decrease in the observed rate of puromycin reaction.  
Regarding sparsomycin resistance, the rRNA structure probing experiments 
suggest that L3 mutants promote an altered conformation of the sparsomycin binding 
site. This (1) may promote increased affinity of ribosomes for sparsomycin, and/or (2) 
impede PTC activation and work in synergy with sparsomycin, to prevent PTC 
transition into the “induced” state. The increased affinity for peptidyl-tRNA observed 
in our biochemical experiments may aggravate these effects by increasing the 
apparent Ka for sparsomycin (as discussed in Results section, page 69 ) 53. 
The observed anisomycin effects and structure probing data complete the 
puzzle. Anisomycin is a competitive inhibitor of peptidyl transfer when puromycin 
and CCA-Phe fragments are used as A-site substrates 193,205. X-ray crystal structures 
show that anisomycin binds in the A-site crevice and sterically interferes with the 
peptidyl moiety of aminoacyl-tRNA. The comparisons of the crystal structures of the 
ribosome at different stages of aminoacyl tRNA selection demonstrated that this 
pocket is unoccupied before accommodation 24,25,44. These observations suggest that 
anisomycin interferes with positioning of the 3’ end of the aminoacyl-tRNA and 




mutants suggest a different resistance mechanism than for sparsomycin. Although 
W255 and P257 are located close to the PTC, the position of other anisomycin 
resistant mutants makes it unlikely that they directly affect anisomycin binding. The 
P18S substitution is located in the middle of the L3 extension, and I282T is located in 
the globular domain of L3 (for a full list of Anr mutants of L3 see Meskauskas A., et 
al 182). Since anisomycin is a competitive inhibitor of the peptidyl transferase reaction 
and CCA-Phe binding 193, the increased rates of the forward reactions of the tRNA 
selection pathway would result in increased occupation of peptidyl transferase center 
by the acceptor end of A-site tRNA, thus promoting anisomycin resistance. The 
biochemical characterizations of the Anr strains demonstrated a direct correlation 
between anisomycin resistance and affinity for Phe-tRNAPhe (Table 1), and 
subsequent characterization of other L3 mutant strains reinforced this notion 204. The 
X-ray crystal structure and results of structure probing experiments provide insights 
into which stages of aminoacyl-tRNA selection may be affected. Intriguingly, the 
W255 and P257 amino acid residues contact C2942 (in S. cerevisiae). This base 
forms the second of two “accommodation gates”. The chemical probing experiments 
demonstrated altered DMS reactivity of the nucleotide bases in helix 89 (U2861 and 
A2863in S. cerevisiae) and at the tip of the sarcin-ricin loop (A2844 in S. cerevisiae, 
Figure 2.12). The base of helix 89 forms the second gate that must be passed by the 
acceptor end of an aminoacyl-tRNA during accommodation 37. An open conformation 
of these gates would decrease the pause associated with the gates and increase the rate 
of accommodation. Alternatively an altered sarcin ricin loop (SRL) structure may 
promote increased rates of GTPase activation, and subsequently accommodation. 




We suggest that the effects of mak8-1, W255C, and P257T forms of L3 on 
tRNA accommodation and conformation of the PTC are functionally linked. The 
accommodation simulation and the induced fit model of PTC activation together 
suggest that accommodation of aa-tRNA triggers changes in PTC conformation. It is 
tempting to hypothesize that L3 (and/or L3 contacting elements) are involved in 
inducing conformational changes in the PTC upon accommodation. First, the W255 
and P257 amino acid residues contact C2941 (in S. cerevisiae), the residue that forms 
the second gate, and with C2944 (in S. cerevisiae). C2941 (in S. cerevisiae) flips in 
the opposite direction and faces toward the peptidyl transferase center. Remarkably, 
the position of C2941 differs between the "uninduced" and "induced" conformations 
of the ribosome. The primary amino group of C2941 (in S. cerevisiae) is within 3.9Å 
of the 3' OH of U2874 (in S. cerevisiae, distance in H. marismortui structure). 
However these two groups may come within hydrogen bonding distance during 
transition into the "induced" conformation. We propose that movement of these bases 
associated with accommodation brings the amino group of C2941 (in S. cerevisiae) 
closer to the 3' OH of U2874 (in S. cerevisiae), allowing formation of this hydrogen 
bond. Formation of the bond promotes/secures the flipped conformation of U2874 (in 
S. cerevisiae) thus switching/locking the PTC conformation in the “induced state” and 
preparing it for peptidyl transfer.   
Accommodation, which is driven by energetically unfavorable conformation 
of the aminoacyl-tRNA, promotes movement of the gate bases 37. This movement 
provides the activation energy required for the subsequent flip of U2874 (in S. 
cerevisiae) and movement of U2952 and U2953 (in S. cerevisiae) during PTC 




amine of C2941 (in S. cerevisiae) and the 3' OH of U2874 (in S.cerevisiae) 
stabilizes/promotes the flipped conformation of U2874 (in S. cerevisiae). Subsequent 
formation of base pairing interactions between the CCA-end of the aminoacyl-tRNA 
and 25S rRNA stabilizes the active conformation of the ribosome by putting it in a 
more stable “energy well”, thus preventing the return to the “uniduced” state. 
 
In this chapter, a biochemical characterization of the L3 mutants has 
been presented. We demonstrated that ribosomal protein L3 affects aminoacyl-
tRNA selection either through conformational changes in active centers of the 
ribosome, or through active participation in structural transitions during the 
elongation cycle. We proposed a model that links accommodation and PTC 
activation, and suggested that (1) process of accommodation triggers an active 
conformation of the PTC, and (2) L3 and (or) L3 contacting elements may be 




Chapter 3.  5S rRNA 
Introduction 
The eukaryotic ribosome is a 4.0-megadalton complex composed of four 
ribosomal RNAs (5S, 5.8S, 18S, and 25S) and multiple proteins. Initial studies of 
ribosomes granted a majority of the catalytic functions to the ribosomal proteins and 
assigned merely a scaffolding role to rRNA. Subsequent biochemical and structural 
studies reversed this model toward assigning an active role to the ribosomal RNA. 
The elucidation of ribosome structures at atomic resolution clearly confirmed the 
active role of rRNA in ribosome function demonstrating that the active centers of the 
ribosome are solely composed of RNA 40,43,166,206. The A- and the P-sites, the majority 
of inter subunit interfaces, the peptidyl transferase, decoding and the GTPase 
associated centers are all composed of the 5S, 18S, and 25S rRNA. Furthermore, 
rRNA is responsible for proper tRNA selection, peptide bond formation and GTPase 
activation 40,166,207,208. Those functions are performed by 18S and 25S rRNAs 166,207. 
The functions of the two small ribosomal rRNAs, 5S and 5.8S, are less well 
understood.  
As the role of rRNA in protein biosynthesis became more apparent in recent 
years, we chose to focus on the role of 5S rRNA in ribosome function and 
translational fidelity. In the ternary ribosomal structure, 5S rRNA connects the active 
centers of ribosome. The “top” part of 5S rRNA is composed of domains II and III 
(Figure 3.1). These domains form the upper part of the central protuberance of the 
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Figure 3.1. Secondary structure of 5S rRNA. 
5S rRNA is composed of five domains (designated by roman numerals), separated by bulges 












Figure 3.2. Anatomy of the large subunit. 
The central protuberance on the large subunit is circled. The 5S rRNA (red) together with ribosomal 
proteins L5 (orange) and L11 (blue) form the main mass of the central protuberance. The L7 stalk 
(raspberry) and SRL (cyan) are shown for orientation. (Based on the Cryo-EM structure of the S. 





protuberance establishes contacts with the small subunit through three intersubunit 
bridges: B1a, B1b, and B1c. Bridges B1b and B1c connect L11 with ribosomal 
protein S15 on the small subunit 59. Domain V of 5S rRNA lies at the base of the 
triple junction of the molecule (Figure 3.1), and interacts with the A-site finger (ASF, 
h38, Figure 3.1) 44,59. Structurally the A-site finger protrudes along the horizontal axis 
of the large subunit and connects the peptidyl transferase center (through helix 80 and 
the P-loop) with the small subunit. The apical part of h38 contacts small subunit 
protein S13 to form the B1a bridge. The B1a bridge is evolutionarily conserved and is 
present in ribosomes from all kingdoms except mitochondriav. The positions and 
contacts of the B1 bridges change during the elongation cycle. Binding of elongation 
factor eEF-2, which catalyzes translocation, promotes a ratchet-like movement of the 
small subunit by approximately 30° 62,209. Upon this rotation, the B1a bridge 
disappears and bridges B1b and B1c are reformed at another position, establishing 
new contacts with the small subunit. Deletion of the B1a bridge in E. coli results in 
increased levels of stop codon suppression, +1 ribosomal frameshifting, and 
decreased rates of EF-G activation 210. This rotation was implicated in defining 
ribosomal binding sites, thus defining the selectivity of the ribosome to the particular 
elongation factor. It is thought that at the start of the elongation cycle the ribosome 
adopts a “locked” conformation, which favors EF-Tu binding and allows accurate aa-
tRNA selection. During or after aa-tRNA selection or peptidyl transfer the ribosome 
transitions to the “unlocked” state. This state promotes EF-G recruitment and allows 
movement of the mRNA by 3 bases in 3’ direction during translocation. The 
subsequent movement of the small subunit presumably puts the ribosome into the 
                                               




locked state, thus preparing it for the next round of the elongation cycle. It is likely, 
that this movement promotes GTP hydrolysis by EF-G which in turn results in 
dissociation of the elongation factor from the ribosome. Deletion analysis of h38 
demonstrated that disruption of the tip of the helix, which participates in formation of 
the B1 bridges, inhibits EF-G activation and promotes mis-sense incorporation. 
Notably, it was demonstrated that ribosomal protein L5, which interacts with the 
opposite side of 5S rRNA, and is spatially close to h38, helps to stabilize P-site 
tRNA:ribosome interactions, and that mutations in L5 affected efficiencies of +1 and 
-1PRF. While the mechanism of these observations in unknown, the proximity of h38 
suggests that L5 (or L5 contacting elements) could be involved in these 
conformational changes, or that it could help to maintain the structure of the 
surrounding areas required for the ribosome transitions. We hypothesize that the B1 
bridges and the central protuberance could be involved in coordination of factor 
selection and regulation of their activities. 
The 5S rRNA“toe” (domain IV, Figure 3.1) makes contact with the triple 
junction formed by h39, h89 and L10. As described above, helix 38 interacts with the 
peptidyl-tRNA through the P-loop and h80. Interestingly, helix 89 forms the gates 
though which the acceptor end of the incoming A-site tRNA slides into the peptidyl 
transferase center 37.  Functional analysis of Thermus aquaticus ribosomes depleted of 
5S rRNA suggested that 5S provides either a structural or functional link between 
domains II and V of 25S rRNAvi. These observations reinforced our hypothesis that 
                                               
vi h39 is part of the domain II; the peptidyl transferase center and h89 composed entirely by the domain 




thr central protuberance and 5S rRNA act to link the different active centers of the 
ribosome, and between large and small subunits. 
To address these hypotheses, we conducted an analysis of a library of 5S 
rRNA alleles mutagenized to near saturation. Previous genetic analysis of 5S rRNA 
was hindered by the presence of four genomic repeats of 5S rRNA. In this work, we 
devised a system allowing expression of mutant alleles as the only source of 5S 
rRNA. Surprisingly, it was found that all but seven of 246 mutant 5S rRNA alleles 
tested were incompatible with viability when expressed as the sole form of the 
molecule. Genetic analyses suggested that the viable alleles might affect the binding 
of peptidyl-tRNA to ribosomes, and rRNA chemical protection experiments using 
ribosomes isolated from these strains revealed changes in chemical protection 
patterns in both 5S and 25S rRNA.  A bioinformatic analysis revealed the apparent 
presence of multiple 5S rRNA alleles in the genomes of all eukaryotes examined. The 
previous observation of allele-specific semi-dominant phenotypes in 5S mutant 
analysis 211 led us to ask whether naturally occurring variants of this molecule might 
also affect translational fidelity. Overexpression of naturally occurring 5S rDNA 
variants in a wild-type RDN1 background indeed resulted in allele-specific changes in 
programmed −1 and +1 ribosomal frameshifting, suggesting that changes in the 





Materials and Methods 
Strains, plasmids and genetic methods 
E. coli strain DH5α was used to amplify plasmids, and E. coli transformations 
were performed using a standard calcium chloride method as described previously 212.  
Yeast cells were transformed using the alkali cation method 170.  YPAD, YPG, SD, 
synthetic complete medium (H-) and 4.7 MB plates for testing the killer phenotype 
were used as described previously 213. Plasmid shuffling techniques using 5-
flouroorotic acid (5-FOA) were performed as previously described 214. For dilution 
spot assays, growing yeast cells in mid-logarithmic phase were initially diluted to 
2×107 colony forming units (CFU)/ml. Subsequently, 105 CFU (5 μl) aliquots, and 
tenfold dilutions from the same cultures thereof were spotted either onto rich medium 
and incubated at 15, 30 and 37 °C, or incubated at 30 °C on rich medium containing 
anisomycin (10μg/ml) or sparsomycin (30 μg/ml). Assays for programmed ribosomal 
frameshifting followed previously described protocols 116,211. These involve the use of 
0-frame control and −1 or +1 ribosomal frameshift test vectors in which the 
production of a reporter enzyme (either firefly luciferase of β-galactosidase) is 
dependent upon a programmed ribosomal frameshift event. Percentage of 
frameshifting is calculated by dividing the enzymatic activities measured from cells 
expressing the frameshift test plasmids by those from cells expressing the 0-frame 
controls, and multiplying the resulting values by 100 %. The nonsense suppression of 
the UAA stop codon has been measured with the dual luciferase reporter system. This 




the frameshift signal has been replaced by the stop codon and translation of the 
second luciferase is possible only as result of the stop codon readthrough (Figure 3.3). 
Ty1 retrotransposition assays were performed using pJEF1105 as previously 
described 215. Briefly, transcription of a neor-tagged Ty1 cDNA clone was induced by 
incubation in 2 % galactose at 20 °C for 3 days, after which cells that had lost 
pJEF1105 were identified by screening for growth on dextrose-containing medium in 
the presence of 5-FOA. The cells were then grown in liquid culture overnight, and 
tenfold dilutions of mid-log cells were spotted onto a medium containing 100 μg/ml 
Gentcin (Life Technologies, Gaithersburg, Md.) to select for cells in which 
retrotransposition had occurred, or onto rich medium as a control. 
The pJD180 series of plasmids contain one complete RDN1 repeat cloned into 
the pRS400 series 216, the pJD106 and pJD209 series consist of high copy vectors 
containing variants of the 5S rDNA gene, and the pJD211 series harbor a single copy 
of the 35S rDNA operon 217.  The pJD373 series of plasmids is based on the pJD211 
series, and contain the C1495U allele in helix 44 of 18S rDNA, which was previously 
shown to confer a recessive hygromycin-resistant phenotype on yeast cells 218.  
Standard oligonucleotide site directed mutagenesis was used to generate the naturally 
occurring allelic 5S rRNA yeast variants (RDN5-2 through RDN5-7) and the RDN5-
Ooc and RDN5-Som hybrids of yeast and Xenopus 5S rRNAs using the RDN5-1 allele 
cloned into pRS424, a high copy TRP1-2µ vector 216 as a template.  
Generation of the rdn1∆∆ yeast strain JD1111, and of strains harboring 
mutant alleles of 5S rDNA on a 2µ-TRP1 vector were performed previously 
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Figure 3.3. Translational recoding reporter systems. 
The bi-cistronic dual luciferase and mono-cistronic β-gal systems were used. Both reporter 
systems allow translation of the sequence downstream from a recoding signal (Firefly luciferase 
for dual luciferase, and the majority of the lac-Z ORF for the β -gal reporter) only as result of 




to contain four telomere proximal 5S rDNA repeats on chromosome XII 219. These 
repeats are deleted in NOY1049 219. Strain JD932 has a complete, wild-type RDN1 
locus. 
Library generation 
To construct a new series of strains lacking the chromosomal 5S rDNA 
repeats, NOY1049 (MATa ade2-1 ura3-1 trp1-1 his3-11 leu2-3, 112 can1-100 
∆rDNA::his3::hisG + pNOY353 (GAL7-35S rDNA, 5S rDNA, TRP1, 2µ, ampr, 
Appendix A, page 161) was transformed with pJD180.Ura. To promote spontaneous 
loss of TRP1 plasmid (pNOY353) transformants were incubated in liquid standard 
defined medium lacking uracil (-ura) for 4 days, streaked for single colonies on –ura 
solid medium, and subsequently replica plated onto medium lacking tryptophan (-trp).  
Trp- auxotrophs were picked and designated JD1248 (MATa ade2-1 ura3-1 trp1-1 
his3-11 leu2-3, 112 can1-100 ∆rDNA::his3::hisG + pJD180.URA).  The observed 
rate of loss of tryptophan prototrophy was approximately 10 %.  JD1253 (MATa 
ade2-1 ura3-1 trp1-1 his3-11 leu2-3, 112 can1-100 ∆rDNA::his3::hisG + 
pJD180.URA [LA-HN M1]) was created by introducing the L-A and M1 viruses into 
JD1248 cells by cytoduction using a previously described technique 133.  
Cytoduction is essentially a mating process that went until the cytoplasmic 
fusion state, but had not proceeded to the nuclei fusion state. JD1248 strain was 
grown on YPAD plates containing a gradient of ethidium bromide from 0 to 10 
mg/ml to promote mitochondria loss. Cells lacking mitochondria (rho0) were selected 
by the inability to grow on a non-fermentable carbon source (glycerol, YPG media). 




JD759 strain harbors the kar1-1 allele of an essential protein required for karyogamy. 
This mutation delays the nuclear fusion thus making it possible to obtain 
intermediates of the mating process that have not progressed to the nuclear fusion 
state. Strains obtained in JD759xJD1248 cross were selected against the JD759 donor 
strain by growth on -Arg media. Diploids were identified by the growth on media 
lacking non essential amino acids (SD). JD1248 colonies with successful cytoplasmic 
transfer (rho+) were identified by the ability to grow on YPG media. The presence of 
the L-A and M1 viruses in these strains were confirmed by the killer assay. Briefly, 
the cells were replica plated 4.7 MB Killer media plates that had been seeded with a 
lawn (0.5 OU at OD595 per 100 mm plate) of 5x47 killer indicator yeast cells (M1 
minus, Appendix A, page 161). Then plates were incubated at 18º C for 2 to 3 days 
and presence of the killer phenotype was scored as a zone of growth inhibition 
surrounding Killer positive colonies. The resulting killer positive strain was 
designated JD1253. 
The JD1253 strain was used to generate stains expressing mutant 5S alleles 
using the plasmid shuffling technique. Plasmid shuffle is the substitution of one 
plasmid for another. JD1253 was transformed with pJD373.Leu harboring 5.8S, 18S 
and 23S rRNA genes, and with one of the 246 variants of pJD106.Trp harboring 
different 5S rRNA alleles (Appendix B, page 166). Transformants were selected on 
media lacking tryptophan and leucine. pJD373.Leu has a recessive hygromycin 
resistance mutation (U1759C) in 18S rRNA, thus allowing negative selection against 
recombinants between pJD373.Leu and pJD180.Ura on hygromycin containing 
media. Spontaneous loss of the pJD180.Ura plasmid was promoted by growth on H-




times, and were subsequently streaked for single colonies on medium lacking 
tryptophan and leucine, and containing 5-flouroorotic acid (5-FOA) 220 and 
hygromycin (300 µg/ml) to negatively select against pD180.Ura. 5S rRNA from these 
obtained strains was sequenced to confirm presence of the mutant alleles. 
rRNA sequencing 
Expression of mutant 5S rRNA was confirmed by a modified single base 
primer extension method 221. In essence, this is a standard primer extension method in 
which sequencing dNTPs/ddNTP mix was substituted for mix of three dNTPs and 
one ddNTP. Excess of ddNTP and the absence of the corresponding dNTP ensures 
nearly 100 % termination at the first base complimentary to the ddNTP, and does not 
continue beyond this base regardless of downstream sequence. Thus the base 3’ of the 
primer can be unambiguously identified as a single base extension using a reaction 
mix containing the corresponding ddNTP. The extension reactions in the three other 
mixes continue to the nucleotide complementary to ddNTP in the reaction mix. Thus 
this method allows detection of even minor contamination by wild type 5S rRNA 
allele. Oligonucleotides complementary to 5S rRNA (Appendix C, page 174) were 
labeled with γ[32P]ATP using T4 polynucleotide kinase, and annealed with 5S rRNA 
isolated from purified ribosomes. Primer extension reactions were performed using 
AMV reverse transcriptase (Roche) in a buffer containing 50 mM Tris–HCl pH 8.3, 
60 mM NaCl, 6 mM magnesium acetate, 10 mM DTT, and chain terminating mixes 
containing 0.25 mM dNTPs (three of the four) plus 0.25 mM ddNTP (the fourth). 
Reactions were incubated at 45 °C for 30 minutes, terminated by the addition of 2 × 





Figure 3.4. rRNA sequencing.  
Example of a single base rRNA sequencing assay at position 81 for a wild type and U81C strains. 
The expected stops from non reacted primers are designated by black bold. The stops resulted from 







electrophoresis thorough 12 % polyacrylamide urea denaturing gels. Labeled bands 
were visualized by autoradiography 
Chemical protection analyses 
Chemical probing with dimethylsulphate (DMS), 1-cyclohexyl-3-(2-
morpholinoethyl) carbodiimide metho-p-toluene (CMCT), and kethoxal (Figure 2.3 
and Figure 3.5), followed by RT primer extension analysis of modified RRNAs were 
performed as previously described 222. The following primers (numbered according to 
first transcribed base) were used: 2,957, 3,057, 1,231, 1,343 and 1,112 for 
S.cerevisiae 25S rRNA, and 99 for 5S rRNA (Table 11). 
Bioinformatic methods 
Genbank was first queried for 5S rRNA sequences according to species.  The 
resulting sequences were then used in BLAST searches 223 to identify homologous 
sequences in the NCBI nucleotide database.  Sequences were hand curated to identify 
those that 1) were represented by multiple independent Genbank accession entries, 
and 2) did not contain overly large deletions of sequence (i.e. did not appear to be 
truncation products or pseudogenes).  The resulting sequences were then aligned with 
one another using ClustalW 224.  
Results 
Generation and characterization of 5S rRNA mutants 
Examination of the yeast strain used for a previous 5S rRNA saturation 




























rRNA gene. To express mutant forms of 5S rRNA in the absence of the wild type 
molecule, strain NOY1049 in which the chromosomal 5S rDNA repeats were 
completely deleted was obtained from the laboratory of M.Nomura 219.  This strain 
was subjected to two additional rounds of genetic manipulation to create a new 
parental strain designated JD1253 (as described in Material and methods, page 92). 
Subsequent attempts to obtain 5SrRNA mutant strains by the plasmid shuffle method 
214 failed due to high rates of recombination between the wild type and mutant forms 
of the 5S gene. Direct sequence analysis of 5S rRNAs from those strains 
demonstrated the absence of expression of the mutant allele. In order to minimize 
recombination and select cells containing only mutant forms of 5S rRNA, a rigorous 
selection scheme involving negative selection for both the wild-type RDN1 gene and 
the plasmid on which it was encoded was devised (see Materials and methods, page 
92). Having established the new strain and selection protocol, we examined the 
effects of all 246 5S rRNA alleles 211 on cell growth and viability. Surprisingly, only 
seven of the alleles supported viability: all the others were unviable when expressed 
as the sole form of 5S rRNA. The seven viable alleles were A20C, C69U, A76U, 
A79G, U81C, A84U and C93U (Figure 3.6). The new mutant strains were first 
characterized with regard to their growth rates at different temperatures. In general, 
expression of each of the seven functional 5S rRNA mutant alleles was associated 
with significantly reduced growth rates at 30 °C compared to wild type. Although 
some of the mutants may have been slightly temperature-sensitive, they were 





Figure 3.6. Direct rRNA sequence analyses of 5S rRNA mutants.  
rRNAs were extracted from ribosomes purified from JD1253 cells expressing wild-type or mutant 
forms of 5S rRNA. Oligonucleotides complementary to 5S  rRNA were labeled with γ[32P]ATP 
using T4 polynucleotide kinase, and annealed with 5S rRNA isolated from purified ribosomes. 
Primer-extension reactions were performed using AMV reverse transcriptase, fractionated by 
electrophoresis through denaturing 12 % polyacrylamide-urea gels, and labeled bands were 
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Figure 3.7. Growth phenotypes of  5S rRNA mutants. 
Mid-logarithmically growing JD1253 cells were diluted to 2×107 colony forming units (CFU)/ml. 
Subsequently, aliquots (5 µl) containing 104 CFU, and tenfold dilutions from the same cultures were 
spotted either onto rich medium (YPAD) and incubated at 15, 30, and 37 °C, or onto YPAD 





Translational inhibitors provide expedient probes for changes in ribosome 
function (reviewed in Ogle J.M. and Ramakrishnan V.22). The seven mutant 5S rRNA 
strains were characterized with regard to anisomycin and sparsomycin sensitivity. 
Both drugs bind in the vicinity of the peptidyl transferase center 186 and severely 
inhibit peptidyl transferase activity 193,225. Though the results with anisomycin were 
generally equivocal, sparsomycin actually improved the growth of all of the mutants 
(Figure 3.7). Anisomycin binds to the A-site hydrophobic crevice, which is occupied 
by the peptidyl moiety of the aminoacyl-tRNA in the absence of the drug. In contrast, 
sparsomycin mainly contacts the peptidyl-tRNA, but also extends into the A-site 
crevice.  The observed drug phenotypes suggest that these mutations in 5S rRNA 
altered the conformation and/or functionality of the P-site, but did not affect the A-
site tRNA.  
Programmed ribosomal frameshifting (PRF) provides a powerful tool to 
monitor translational fidelity 116. The PRF signals from two endogenous yeast viruses, 
L–A (which utilizes a −1PRF mechanism) and the Ty1 retrotransposable element 
(which uses +1PRF) were employed to monitor the effects of the 5S alleles on these 
processes using dual-luciferase reporter plasmids 226. All seven of the viable mutants 
promoted no changes in −1PRF, and had no effect on the "Killer" phenotype.  In 
contrast, a few of the mutants promoted modest but statistically significant changes in 
+1PRF. Ty1 retrotransposition frequencies were most strongly reduced by those 
alleles that promoted the largest increases in +1PRF (Figure 3.8), thus confirming the 

























































































































































































Figure 3.8. Efficiency of translational recoding events.  
Translational recoding efficiencies are not affected in most of the viable 5S mutants. However, while 
changes in +1PRF efficiencies (plotted as percent of frameshifting) are small but biologically 




In the context of current PRF models, -1PRF is kinetically driven by 
accommodation of A-site tRNA, while +1 frameshifting is primary affected by 
conformation and status of the P-site.  The observed PRF and viral maintenance 
phenotypes reinforce the notion that mutations in 5S rRNA primary affect the P-site 
of the ribosome. 
Structural characterization of ribosomes containing mutant forms of 5S rRNA 
Isolated ribosomes containing only mutant forms of 5S rRNA were probed in 
vitro for structural changes in 25S and 5S rRNAs using three base-specific reagents: 
dimethylsulfate (DMS), kethoxal, and 1-cyclohexyl-3-(2-morpholinoethyl) 
carbodiimide metho-p-toluene (CMCT). DMS preferentially donates a methyl group 
to hydrogen bond accepting ring nitrogens of C, G and A residues 196,227; kethoxal 
reacts with the N1 and N2 amine of solvent exposed G residues 228,229, and CMCT 
reacts with non-interacting N1 and N3 nitrogens of G and U residues, respectively 230. 
Base modifications by these reagents cause n−1 reverse transcriptase stops, allowing 
for identification of base-specific changes in rRNA structure. Reverse transcription 
analysis was employed to monitor structural changes in domains II, V and VI of 25S 
rRNA, and throughout the entire length of 5S rRNA. 
The results of these studies revealed that the mutants showed structural 
changes in both 5S and 25S rRNAs. Figure 3.9 shows representative autoradiograms 
from these studies, and Figure 3.10 depicts the bases in question in relation to two-







Figure 3.9. Chemical protection analyses.  
Ribosomes purified from JD1253 cells expressing either wild-type or mutant 5S rRNAs were 
chemically probed with DMS, kethoxal and CMCT. The representative autoradiograms depicting 
probing of 5S rRNA (U81C and A79G) and 25S rRNA (A20C) are shown. M indicates 
corresponding RDN5 mutant, wt indicates ribosomes containing expressing RDN5-1allele, and Unm 
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Figure 3.10. Summary of the chemical protection analyses.  
Ribosomes purified from JD1253 cells expressing either wild-type or mutant 5S rRNAs were 
chemically probed with DMS, kethoxal and CMCT. The products of reverse transcriptase primer 
extension reactions were subjected to PAGE analysis on denaturing PA-urea gels, and visualized by 
autoradiography. Color code shows summary of the effects of pure mutants mapped onto 5S rRNA 
and the helix 95-sarcin/ricin loop (SRL) region of 25S rRNA. The open circles indicate positions of 
wild-type bases, and the arrows indicate the relevant mutant alleles. The color-coded bars indicate 
which mutant 5S rRNAs alter the chemical reactivities of other similarly coded, circled, bases in 5S 




reactivities of three bases in 5S rRNA were specifically altered by the mutations. In 
particular, in all of the mutants (with the exception of C69U), G85, which is normally 
unpaired, was protected from chemical modification. Allele-specific effects were also 
observed with regard to G91 and A92, which lie in the loop D region of the molecule: 
all of the mutants except A84G promoted increased protection at position G91, while 
only U81C altered the protection pattern of A92. Two of the 5S rRNA mutants also 
had effects on 25S rRNA. Specifically, the A20C and U81C alleles conferred 
protection of G3027, and weaker but consistent reactivity at position U3013. 
Interestingly, G3027 is located in the sarcin/ricin loop (SRL), which is involved in 
elongation factor binding (Figure 3.10). 
Naturally occurring allelic variants of 5S rRNA specifically inhibit programmed 
−1 ribosomal frameshifting 
Eukaryotic genomes contain >100 copies of rDNA genes. It is generally 
assumed either that they are all identical, or that minor differences are 
inconsequential. Alternatively, it is possible that allelic 5S rDNA variants may have 
been functionally selected for. To examine this issue, GenBank was searched for 
species-specific 5S rDNA alleles that fulfilled the following criteria (1) each variant 
had to be represented by multiple independent entries, and (2) obvious pseudogenes 
(e.g., those containing large deletions or insertions) were rejected. These searches 
revealed the presence of multiple 5S rDNA alleles in every genome examined. 
Specifically, the S. cerevisiae genome contains at least seven different allelic variants, 





 Drosophila melanogaster has ≥11 (Figure 3.11). To test the hypothesis that different 
forms of 5S rRNA may differentially affect translational fidelity, site-directed 
mutagenesis was used to create the seven naturally occurring yeast 5S rRNA allelic 
variants vii, and these were expressed from high-copy-number 2μ vectors. All but the 
“wild-type” (RDN5-1) variants of the molecule were inviable, either as the sole form 
of 5S rRNA (in JD1253 cells), or in the presence of four chromosomal copies (in 
JD1111 cells) (data not shown). Intriguingly, expression of the RDN5-7 variant in a 
wild-type RDN1 strain background (JD932) resulted in significant inhibition of 
−1PRF (Figure 3.12). 
Effects of hybrid yeast/Xenopus 5S rRNAs on programmed ribosomal 
frameshifting 
Early studies of 5S rRNA in X. laevis revealed that ribosomes isolated from 
oocytes and somatic cells contained different forms of 5S rRNA 231. In light of the 
observation that 5S rRNA allelic variants can have differential effects on translational 
fidelity, we hypothesize that Xenopus may use the two different forms of 5S rRNAs 
to post-transcriptionally regulate gene expression during the embryonic development 
program. To examine this question, yeast 5S rRNA clones were mutagenized to 
mimic the Xenopus oocyte and somatic 5S rRNA variants. Specifically, bases in yeast 
5S rRNA at positions 30, 48, 54, 56 and 57 were altered to the corresponding residues 
in either Xenopus somatic (RDN5-som), or oocyte (RDN5-ooc) 5S rRNAs (Figure 
3.11). Although both forms were inviable in JD1253 
                                               
vii Recent addition to SGD database describes seven copies of 5S rDNAin S.cerevisiae genome. The 
SGD allele RDN5-1 corresponds to the RDN5-1 allele in this study, and SGD alleles RDN5-2 – RDN5-




Alignments of S. cerevisiae 5S rRNA allelic variants. 
RDN5-1    GGTTGCGGCCATATCTACCAGAAAGCACCGTTTCCCGTCCGATCAACTGTAGTTAAGCTG 60 
RDN5-7    GGTTGCGGCCATATCTACCAGAAAGCACCGTTTCCCGTCCGATCAACTGT-GTTAAGCTG 59 
RDN5-3    GGTTGCGGCCATATCTACCAGAA-GCACCGTTTCCCGTCCGATCAACTGTAGTTAAGCTG 59 
RDN5-2    GGTTGCGG  CCATATCTACCAGAAAGCACCGTTTCCCGTCCGATCAACTGTAGTTAAGCTG 60 
RDN5-6    GGTTGCGGCCATATCTACCAGAAAGCACCGTTTCCCGTCCGATCAACTGTAGTTAAGCTG 60 
RDN5-5    GGTTGCGGCCATATCTACCAGAAAGCACCGTTTCCCGTCCGATCAACTGTAGTTAAGCTG 60 
RDN5-4    GGTTGCGGCCATATCTACCAGAAAGCACCGTTCTCCGTCCGATCAACTGTAGTTAAGCTG 60 
          *********************** ********  **************** ********* 
 
RDN5-1    GTAAGAGCCTGACCGAGTAGTGTAGTGGGTGACCATACGCGAAACTCAGGTGCTGCAATC 120 
RDN5-7    GTA-GAGCCTGACCGAGTA-TGTAGTGGGTGACCATACGCGAAACTCAGGTGCTGCAATC 117 
RDN5-3    GTAAGAGCCTGACCGAGTAGTGTAGTGGGTGACCATACGCGAAACTCAGGTGCTGCAATC 119 
RDN5-2    GTAAGAGCCTGACCGAGTAGTGTAGTGGGTGACCATACGCGAAACTCAGGTGCTGCAGT- 119 
RDN5-6    GTAAGAGCCTGACCGAGTAGTGTAGTGGGTGACCATACGCGAAACTCAGGTGCTGCA--- 117 
RDN5-5    GTAAGAGCCTGACCGAGTAGTGTAGTGGGTGACCATACGCGAAACTCAGGTGCTGCATTC 120 
RDN5-4    GTAAGAGCCTGACCGAGTAGTGTAGTGGGTGACCATACGCGAAACTCAGGTGCTGCAATC 120 
          *** *************** *************************************    
 
RDN5-1    T 121 
RDN5-7    T 118 
RDN5-3    T 120 
RDN5-2    - 
RDN5-6    - 
RDN5-5    T 121 
RDN5-4    T 121 
 
Alignment of X. lavae 5S rRNA allelic variants. 
RDN5-ooc  GCCTACGGCCACACCACCCTGAAAGTGCCTGATCTCGTCTGATCTCAGAAGCGATACAGG 60 
RDN5-som  GCCTACGGCCACACCACCCTGAAAGTGCCCGATCTCGTCTGATCTCGGAAGCCAAGCAGG 60 
          ***************************** **************** ***** *  **** 
 
RDN5-ooc  GTCGGGCCTGGTTAGTACCTGGATGGGAGACCGCCTGGGAATACCAGGTGTCGTAGGCTT 120 
RDN5-som  GTCGGGCCTGGTTAGTACTTGGATGGGAGACCGCCTGGGAATACCAGGTGTCGTAGGCTT 120 
          ****************** ***************************************** 
 
RDN5-ooc  - 
RDN5-som  T 121 
 
Figure 3.11. Allelic variants of 5S rRNAs in eukaryotic genomes.  
Conservation of multiple 5S rDNA alleles in eukaryotic genomes. GenBank was first queried for 5S 
rRNA sequences according to species, and the resulting sequences were used in BLAST searches 
(Altschul et al. ) to identify homologous sequences in the database. Sequences were hand curated to 
ensure their validity, and then aligned with one another. RDN5-som and RDN5-ooc show the 
























































































































Figure 3.12. Semi-dominant effects  of naturally occurring yeast and hybrid yeast/Xenopus 5S 
rRNA alleles on L–A directed −1, and Ty1 promoted +1PRF. 
Using the yeast RDN5-1 allele cloned into a high-copy-number 2μ vector, oligonucleotide-primed 
site-directed mutagenesis was used to create the other six naturally occurring yeast RDN5 alleles 
(RDN5-2 to RDN5-7), and the hybrid yeast/Xenopus RDN5-ooc and RDN5-som alleles (see Figure 
3.11). These alleles were episomally expressed in JD932 cells, a wild-type yeast strain containing a 
full complement of chromosomal rDNA genes. Programmed −1 and +1 ribosomal frameshifting 
efficiencies were monitored with β-gal reporter plasmids as described in Materials and methods, 





 and JD1111 strain backgrounds, overexpression of RDN5-ooc in JD932D 
background promoted significant and specific inhibition of −1PRF in the context of 
the wild-type RDN1 locus (Figure 3.12). The potential significance of these findings 
is discussed below. 
Discussion 
This study represents the first structure/function analysis of 5S rRNA in a 
eukaryotic system. Having established a new yeast strain and selection protocol, we 
examined the effects of all 246 5S rRNA alleles 211 on cell growth and viability. The 
observation that only seven of the alleles were viable when expressed as the sole form 
of 5S rRNA can be interpreted in several ways. First, it could imply that 5S rRNA 
plays a critical role in ensuring the proper functioning of the ribosome. Alternatively, 
the mutations in 5S rRNA may result in a lethal phenotype not associated with protein 
synthesis. All rRNAs except 5S rRNA are transcribed by the RNA polymerase I as a 
single 35S transcript. In the nucleolus, pre-rRNA is modified and cleaved in the 
cascade of subsequent reactions that produces 25S, 18S and 5.8S rRNA 232,233. In 
contrast, RDN5 is transcribed by the RNA polymerase III from an internal promoter 
located within first 20 nucleotides of the coding sequence and the 5’ end of 5S rRNA 
is defined by the transcription start site 234,235. Subsequent trimming of the five 
nucleotides from 3’ end by the SNIP complex produces the mature molecule 236. 
Transcription of 5S rRNA is autoregulated by a feedback mechanism that involves 
TFIIIA 237 and ribosomal protein L5 238,239. TFIIIA is an essential transcription factor 
for RNA polymerase III and is required for transcription of Pol III genes including 5S 




forms a 7S complex 242-244. Formation of the complex exposes a nuclear export signal 
of the TFIIIA and triggers nuclear export of the 7S complex through the Ran pathway 
245. In the cytoplasm, ribosomal protein L5 promotes release of TFIIIA and formation 
of the L5:5S rRNA complex 246. Binding of 5S rRNA exposes the L5 nuclear 
localization signal and activates nuclear import of the RNA-protein complex 247,248. 
This feedback loop regulates L5 and 5S rRNA expression and ensures stoichiometric 
proportions of L5 and 5S rRNA in the nucleus (Figure 3.13). Regions of the protein – 
RNA interactions span a substantial part of the 5S rRNA molecule. L5 interacts with 
helix III and loop C of 5S rRNA 249, and 7S complex formation requires helices II 
through IV (Figure 3.10) 246. Integrity of the feedback regulation loop is essential for 
viability and development of Xenopus lavae oocytes and for viability of S. cerevisiae 
250,251. Therefore mutations in the promoter region and regions of 5S rRNA, which are 
required for L5 and TFIIIA interaction, may result in lethality unassociated with 
protein synthesis. 
Identification of seven mutants that were viable as the sole forms of 5S rRNA 
has made possible the first structure/function analysis of this molecule in a eukaryotic 
system. Functionally, the ability of these mutants to antagonize the effects of 
sparsomycin, which increases binding of peptidyl-tRNA to the P-site 205,252, suggests 
that they may promote decreased binding of peptidyl-tRNAs; similar observations 





Figure 3.13. The autoregulation loop of 5S rRNA and TFIIIA. 




 are located within the L5 binding site (Figure 3.14), thus 5S:L5 interactions may 
promote sparsomycin resistance through a similar mechanism. Interestingly, C69U, 
A76U, A79G, U81G and A84C are all clustered in the region that interacts with  the 
A-site finger (h38, Figure 3.14) 184. The base of the A-site finger contacts with h39 
and the P-loop (h80), thus connecting 5S rRNA to the peptidyl transferase center and 
the P-site. Therefore, these mutants may promote sparsomycin resistance by affecting 
the structure/function of the peptidyl transferase center. Surprisingly, these mutants 
did not show any anisomycin associated phenotypes, implying that 5S specifically 
interacts and communicates with the P-site but not with the A-site of the ribosome. 
The last mutant, C93U is located in the D-loop of 5S rRNA (Figure 3.14). Though the 
D-loop contacts several important regions on the ribosome, including h89, h41 and 
ribosomal protein L10, it is remote from the P-site associated structural components. 
Thus the observed effect of C93U is on +1PRF and anisomycin resistance is probably 
indirect.  
Chemical protection studies amend this hypothesis. All of the mutations 
influenced chemical reactivities of nucleotides G85 and G91 in 5S rRNA (Figure 
3.10). G85 is located in the A site finger binding region and G91 is a part of the D-
loop. There are only two partial exceptions to this rule: C69U substitution does not 
affect G85 but resulted in de-protection of G91, and G84 does not affect G91 but 
influences the chemical reactivity of G85. Thus mutations resulting in sparsomycin 
resistance are either located in the areas of interactions between 5S rRNA and L5, or 





















Figure 3.14. Position of the viable mutations of 5S rRNA in the 3D ribosomal structure. 
The viable 5S rRNA mutants (red spheres) interact with ribosomal protein L5 (A20C), h41 (depicted 
in yellow, C93U) and clustered in the region of contact with h38 (shown in gray, mutants A76U, 
A79G, U81C and A84C). Bases of the inner core of the PTC are shown by red stick models. Helix 
89 is shown in blue. (Based on the Cryo-EM structure of the S. cerevisiae ribosomes from Spahn 






These observations together suggest that 5S rRNA, L5 and the A-site finger (h38) 
contacts are important for proper functioning of the peptidyl transferase center, as 
previously observed in cells expressing mutant derivatives of ribosomal protein L5 
169. The observation that 5S rRNA alleles also affect Ty1 retrotransposition and 
+1PRF, which requires slippage of the peptidyl-tRNA are consistent with this 
conclusion. It is possible that 5S rRNA participates in a structural rearrangement 
pathway that promotes a communication between the P-site, the PTC, and the other 
active centers of ribosome through the contacts with L5 and helix 38.  
Intriguingly, two mutants A20C and U81C affected protection of nucleotides 
located in the sarcin-ricin loop (U3013 and G3027 Figure 3.10)viii. These findings 
suggest that the SRL and GTPase associated center are influenced by 5S rRNA, most 
likely through mutual interactions with h38. 
As a final consideration, why do multiple 5S rDNA alleles appear to be 
retained in eukaryotic genomes? We found that the RDN5-7 allele had a semi-
dominant effect on L–A directed −1PRF. This is the first demonstration that a 
naturally occurring allele of a ribosomal component can affect this aspect of 
translational fidelity. We recently demonstrated that -1PRF signals may act as mRNA 
destabilizing elements and influence mRNA stability by the efficiency of 
frameshifting 141. A search of the yeast genome database identified a large number of 
functional -1PRF signals that can potentially act as mRNA destabilizing elements and 
thus regulate gene expression 106. We hypothesize that at least some 5S rRNA 
sequence variants may have been evolutionarily selected to allow for fine tuning of 
                                               
viii The sarcin-ricin loop is located on the solvent side of the large subunit and it is a functionally 
important component of the factor binding site. Cleavage of the sarcin-ricin loop results in irreversible 




gene expression at the post-transcriptional level. Interestingly, the 5S rRNA-
ribosomal protein L5 complex is assembled onto large subunits late in ribosome 
biogenesis, and this complex can be dissociated from and re-associated onto core 
large subunits 239,254. Thus, different versions of 5S rRNA could be added onto newly 
synthesized core 60S subunits, allowing cells to rapidly alter the -1PRF efficiency of 
newly synthesized ribosomes and thus regulate stability of actively translated mRNA.  
Studies using the yeast/Xenopus hybrids lend support to this suggestion. 
Expression of RDN5-ooc allele resulted in two-fold inhibition of -1PRF in the 
presence of wild type 5S rRNA. In X. lavae, expression of two alleles of 5S rRNA, 
oocyte and somatic, is strictly regulated during development. An unfertilized egg 
contains only the oocyte form of 5S rRNA. At this stage only a minor fraction of 5S 
rRNA is incorporated into the ribosomes and a majority of 5S is stored in the 
cytoplasm in a complex with TFIIIA. Upon fertilization, the oocyte form of 5S rRNA 
is transferred into the nucleus and it is incorporated into newly assembled ribosomes. 
Release of TFIIIA activates transcription of 5S rRNA, most of which is the somatic 
form. During development, the somatic form of 5S rRNA is gradually substituted in 
place by the oocyte version. As a result, somatic cells do not contain of oocyte the 
form 5S rRNA. Expression of the somatic form of 5S rRNA may result in increased 
levels of -1PRF, which would serve to destabilize -1PRF containing messages. Thus 
the switch between the different forms of 5S rRNA could be responsible for the rapid 





In conclusion, the first analysis of 5S rRNA in a eukaryotic system has been 
presented. Our observations suggest that 5S rRNA is an important functional 
component of the ribosome. We demonstrated that 5S rRNA may be involved in 
communication between P-site and other functional centers of the ribosome, 
likely through interactions with the A-site finger and ribosomal protein L5. 
Analysis of expression of naturally occurring alleles in S. cerevisiae, suggests that 
5S rRNA may be involved in post transcriptional regulation of gene expression 




Chapter 4.  Ribosomal protein L10 
Introduction 
Ribosomal protein L10 was initially identified in yeast in a screen for mutants 
that were synthetically lethal with a deletion of subunit 6 of cytochrome bc1 257. 
Subsequent genetic studies demonstrated that QSR1, as it was named, was essential 
for protein synthesis and allelic to RPL10 258,259. L10 is required for formation of 80S 
ribosomes, and mutations in RPL10 specifically affect large subunit maturation and 
subunit joining 260,261. Studies of ribosomal export demonstrated that L10 
incorporation is the last step required for production of mature 60S subunits. Nearly 
mature large subunits, lacking L10, are exported from the nucleus to the cytoplasm in 
complex with an export adapter protein called Nmd3p via the Crm1p pathway 262,263. 
Upon export, a complex formed by L10 and Sqt1p binds to the large subunit, 
promoting release of Nmd3p followed by incorporation of L10 264. Release of Nmd3p 
from the large subunit requires L10 and GTP hydrolysis by the G-protein Lsg1p 265. 
Mutations that affect Lsg1p activation, or replacement of GTP with non-hydrolysable 
GTP analogs traps Nmp3p in the complex with L10, Sqt1p, and the large subunit 266.  
It is thought that Sqt1 plays a dual role: (A) it co-translationally binds L10 and acts as 
a chaperone by stabilizing newly synthesized L10 267; and (B) it provides a scaffold 
for interactions between L10 and the large subunit 266 .  
These observations suggest that L10 may itself play a major role in subunit 
joining and translation, and (or) that L10 integration into the large subunit promotes 




cryo-EM structure of the 80S yeast ribosome showed that there are no contacts 
between small subunit components and L10 59, thus making direct involvement of 
L10 in subunit joining unlikely. In the ternary ribosome structure, L10 protrudes from 
the cytoplasmic side of the large subunit starting from the base of the L7/L12 stalk 
toward the peptidyl transferase center. L10 is sandwiched between h38 and h89, and 
its tip interacts with h39 59. The contacts that L10 makes with h38, h39 and the P-loop 
establish its connection with the peptidyl transferase center. Interestingly, domain V 
of 5S rRNA makes contact with a junction formed by L10, h38 and h39, but does not 
establish direct contact with L10 (Figure 4.1). The L10 protein of yeast is larger then 
bacterial homologs, and its C-terminal domain together with an extension of h38 
forms a large unresolved mass next to the L7/L12 stalk 59. Thus, elucidation of the 
functional role of L10 may reveal structural and conformational features required for 
subunit joining, translation initiation and subunit maturation.  
Toward the goal of furthering our understanding of L10, we randomly 
mutagenazied RPL10 and screened a primary library of mutants for the inability to 
maintain the killer phenotype. This approach was based on the rationale that 
propagation of the L-A and M1 viruses of yeast depends on multiple factors such as 
-1PRF, the correct ratio of 40/60S subunits, and the efficiency of protein synthesis. 
Thus we reasoned that this approach would result in identification of mutants that 
affect multiple stages of protein synthesis. This screen identified 56 new rpl10 alleles. 
























Figure 4.1. Position of L10 in the ternary ribosomal structure 
L10 is sandwiched between h38 and h89. The PTC proximal region of L10 is restricted by h38. The 
C-terminal part of L10 (unresolved in this structure) contacts with the L7/L12 stalk. (Based on the 




 sensitivity/resistance to cold (15 °C), heat (37 °C), anisomycin, and paromomycin 
(Figure 2.2 and Figure 4.2). Efficiencies of -1PRF and non-programmed suppression 
of the UAA nonsense codon were measured using a dual-luciferase reporter system.  
Biochemical characterization demonstrated effects of rpl10 alleles on ribosome 
biogenesis and affinities for aminoacyl-tRNA. These analyses: (A) reveal functionally 
important regions of ribosomal protein L10; and (B) suggested that h38 (the “A-site 
finger”) and the loop at the base of helix 89 (components of the “accommodation 
gates”) are required for proper ribosomal function and aminoacyl-tRNA selection.  
Material and methods 
Strains, media and genetic methods 
Yeast and E. coli media were prepared as previously described 171,212. Yeast 
transformation, cytoduction and Killer virus maintenance assays were conducted as 
previously described 170,268. E. coli DH5α was used to amplify plasmid DNA. Strains 
used in this study are listed in the Appendix A, page 162. Specifically, JD1238 
(MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 pJD429.URA,  L-A HN M1) was 
used as a parental strain for the expression of RPL10 alleles. Cold, heat and drug 
resistance were measured by dilution spot assays. Cell cultures were grown at 30°C to 
mid-logarithmic phase, and then 10 fold dilutions of cell (from 105 to 10 CFU) in 5µl 
aliquots were spotted on appropriate media and grown for 3 – 5 days. Qualitative 





























were assigned to resistant strains and negative scores were assigned to sensitive 
strains. Efficiencies of -1PRF and nonsense suppression were measured using a dual 
luciferase reporter system as previously described 226. Reporter plasmids are listed in 
Appendix B, page 165. 
Random mutagenesis of RPL10 
A library of plasmid-borne rpl10 mutants was constructed using the error-
prone PCR and gap repair method 269. Mutagenesis primers (70 nucleotides) for PCR 
were designed to be complementary to the 5' and 3' untranslated regions of RPL10 
and included translational start and stop codons: (forward, RPL10_RMF; reverse, 
RPL10_RMR, Appendix C, page 177). Random mutagenesis was performed with the 
GeneMorph II PCR random mutagenesis kit with template concentrations optimized 
to generate between one and four mutations per RPL10 coding sequence. pJD589 was 
digested with StuI. The linearized plasmid lacking the RPL10 coding sequence was 
purified by Tris-acetate-EDTA-agarose gel electrophoresis and cotransformed with 
the randomly PCR-mutagenized RPL10 coding sequences into JD1238 cells. After 3 
days of growth on selective medium (H-trp), cells that had lost the wild-type RPL10-
containing plasmids were selected by replica plating onto 5-fluoroorotic acid (5-
FOA)-containing medium 214. Colonies were arrayed onto H-trp plates and 
subsequently replica plated onto a lawn of 5x47 cells (MATa/MATα his1/+ trp1/+ 
ura3/+ K–, Appendix A, page 160) to identify K- colonies. Approximately 3000 
colonies were screened. Plasmids were rescued into E.coli from yeast strains that had 
lost the killer phenotype. Plasmids were reintroduced into JD1238 cells and rescored 




times, in order to prevent identification of false positive strains due to spontaneous 
Killer virus loss. Only those strains that were confirmed as unable to maintain killer 
phenotype were selected as new rpl10 alleles. 
Polysome profiles 
50 ml cell cultures were grown in YPAD media to OD595 of 0.5-0.7. Cells 
were rapidly mixed with 50ml of ice cold buffer L [20 mM Tris-base, 50 mM KCl, 
and 12 mM MgCl4, 1 mM DTT, 200 µg/ml cycloheximide] and collected by 
centrifugation using a table top centrifuge at 4000 rpm for 10 minutes at 4 °C. Cell 
pellets were re-suspended in 50 ml of ice cold buffer L and again collected by 
centrifugation for a second time.  Cells were then re-suspended in ~1 ml of buffer L 
and mixed with equal volumes of 0.5 mm glass beads. Cells were disrupted in a Mini 
Beadbeater at 4 °C using 4 pulses of 1 minute each with 2 minutes intervals allowing 
for cooling.  Cell debris was removed by centrifugation in a microcentrifuge at 15000 
rpm for 15 minutes at 4 °C. Supernatants were collected, and 6 OU at OD280 in 200 µl 
were applied to the top of a 13 ml sucrose gradient. Linear 7-47 % sucrose gradients 
were prepared by mixing buffers A [20 mM Tris-base, 50 mM KCl, 12 mM MgCl4, 1 
mM DTT, 200 µg/ml cycloheximide, 7 % sucrose] and B [20 mM Tris-base, 50 mM 
KCl, 12 mM MgCl4, 1 mM DTT, 200 µg/ml cycloheximide, 47 % sucrose]. Cell 
lysates were separated by centrifugation in SW-41Ti rotor at 40000 rpm for 3 h at 4 
˚C. Gradients were subsequently developed using an ISCO-5 gradient fractionator. 
Continuous OD254 readings were recorded and resulting hard copy charts were 





aa-tRNA synthesis and aa-tRNA binding 
Synthesis of aminoacyl-tRNA and aminoacyl-tRNA binding experiments 
were performed as described in Chapter 2, page 56.  
Analysis of aa-tRNA binding data 
The field of ribosomal biochemistry was established in a period from late 
1960 to the early 1970’s. At that time, data analysis was hindered by a lack of 
computational resources. Thus researchers were forced to use linearization 
approaches to analyze these non-linear data. In the ribosome-ligand interaction field, 
the reciprocal approach, often referred as the Scatchard plot, became widely utilized 
and became the de facto standard 183,252,270-272. In this approach, the single site binding 












where ][ 0RS  is initial concentration of the ribosomes, ][ RStRNA • is the 
concentration of the complex of tRNA and ribosomes, and ][tRNA  is the free tRNA 
concentration. Division of both sides of equation by ][ 0RS  and subsequent 





. In the first case the plot of ]/[tRNAv  vs. v  is linear with a 
negative slope equal to dK . In the second case, charting v  vs. ]/[tRNAv  also 
provides aK as a negative slope. Both methods proved to be useful in the absence of 
computationally unattainable alternatives.  However, both approaches distort the data 




assumes that the point distribution is normal and that the standard deviation is the 
same at every point on the abscissa. Obviously these transformations disturb the data 
point distribution. Secondly, the transformations introduce the error in the abscissa 
coordinates. Since the linear regression algorithm (sum of least squares) minimizes 
vertical distances between data points and the fitted curve, it is erroneous to use it due 
to error introduced both into both abscissa and ordinate coordinates. In addition this 
approach hinders analysis of multiple binding sites and adjustments for non-specific 
binding 273. 
In our previous work on ribosomal protein L3 we illustrated the validity of our 
biochemical methods and their compatibility with historically accepted analytical 
methods. Since adequate computational resources are now available there is no reason 
to continue utilizing Scatchard plot analysis. Thus in this study, nonlinear regression 
analysis of binding data was done by SigmaPlot 9.0 and GraphPad Prism 4.0 
software. Two models have been used: 1) binding with ligand depletion and 2) 
binding with ligand depletion and non specific binding. In case of ligand depletion, 
the concentration of free ligand is significantly different from the initial ligand 
concentration. Application of ][][][ 0 RStRNAtRNAtRNA •−=  and 









tRNARSRStRNA ][][][ ∗=• ) yields: 
0]][[])][]]([[][ 0000
2 =+++•−• tRNARSKtRNARSRStRNARStRNA d . Solution of 
the second order equation results: 
2
4][




])][]([ 00 dKtRNARSb ++−= , and ]][[ 00 tRNARSc = . The binding data have been 
fitted into this equation constraining ][ 0RS  and dK  to positive values.  
The non specific binding with ligand depletion model is similar to the ligand 
depletion model. Assuming that the dissociation constant for non specific binding is 
much higher than for the ][ RStRNA •  complex, the binding isotherm for nonspecific 







=• . Application of 
][][][ 0 RStRNAtRNAtRNA •−=  and ][][][ 0 RStRNARSRS •−=  substitutions to this 
equation produces: 
0]][[])][]]([[][ 0000
2 =+++•−• tRNARSKtRNARSRStRNARStRNA d  







where )][2][]([ 000 NStRNANSKKtRNARSb dd ++++−= , NSa += 1 , and 
])[][]([ 000 RSNStRNANSKtRNAc d ++= . The binding data have been fitted into this 
equation with ][ 0RS , dK , and NS constrained to positive values. Then using the 
obtained results, data have been plotted on Scatchard plot for visualization purposes.  
Results 
Identification of new rpl10 alleles by random mutagenesis 
Previous studies identified rpl10 alleles affecting large subunit maturation and 




findings encouraged us to pursue an in depth analysis of L10 function. Previously 
known rpl10 alleles were identified by their temperature sensitive phenotypes. 
Examination of these alleles in a new strain background, that better mimics genomic 
expression of L10, revealed that they had no effects on virus maintenance and 
resistance toward translational inhibitors 274. To identify mutants that affect these 
processes, a large-scale mutagenesis project involving both random and site-specific 
PCR mutagenesis was devised.  Mutants were primarily screened for loss of the M1 
virus based on the rationalization that this approach would yield alleles that promoted 
translational defects. To this end, the coding region of RPL10 was subjected to 
random PCR mutagenesis (avg. 1-4 mutations per PCR product) and screened for loss 
of the killer phenotype as described in the Materials and methods.  The mutant 
RPL10-HIS3 plasmids were rescued from killer minus strains, passaged through E. 
coli, re-introduced into rpl10∆ cells, and re-scored for their abilities to promote M1 
virus loss. Approximately 15 % of the mutants were lethal as determined by their 
inability to grow in the presence of 5-FOA (data not shown). Due to an ~10 % 
intrinsic rate of killer loss in the JD1293 strain background, the plasmid rescue and 
reintroduction procedure was performed three times to avoid false positive results. In 
the end, the mutations responsible for conferring K- phenotype were identified by 
DNA sequence analysis. In a screen of >3,000 colonies, 56 killer minus mutants were 
identified. These included 35 single mutations, 19 double mutations, 1 triple 
mutation, and 1 C-terminal 7 amino acid deletion mutant.  The large number of alleles 
with single amino acid substitutions allowed exclusion of alleles with multiple 
mutations from subsequent analysis.  Among the single mutants, multiple 




frequencies of mutations were mainly located at the N-terminal and middle parts of 
the protein. These regions span amino acids 7-17, 59-94, and 144-152. 
Temperature and drug specific phenotypes 
Spot assays of 10-fold dilutions were used to determine relative degrees of 
cold, heat, anisomycin, and paromomycin resistance. The results are shown in Figure 
4.3 and Figure 4.4. We have not observed a direct correlation between temperature, 
drug resistance and killer loss. One cold sensitive and two cold resistant strains were 
found. Surprisingly, no heat sensitive mutants were identified (Table 2 and Figure 
4.3).  
Thirteen anisomycin resistant and four sensitive strains were identified. In the 
ternary ribosomal structure, anisomycin resistant/sensitive mutants are located in the 
region where L10 interacts with h89 and h38/39. Residues R7, Y9 and L152 contact 
with helix 89. Amino acids K15, Y17, P93 and F94 are located on the surface of L10 
that interacts with h38, and V26 lies in the base of the residues P93 and F94. I120 is 
positioned in a tip of L10 close to the junction between helixes 38 and 39. 
Interestingly, G81 is located on the solvent side of the ribosome and does not contact 
any other parts of the 60S subunit in the mature ribosomal particle (Table 2, Figure 
4.4, and Figure 4.5).  
Paromomycin resistance was used to probe for defects associated with 
interactions between the small and large subunits. Paromomycin increases 
incorporation of mis-sense tRNAs and suppression of termination 275,276. It binds to 





Figure 4.3. Heat and cold resistance phenotypes of L10 mutant strains. 
Strains harboring mutant alleles of ribosomal protein L10 were grown to mid-logarithmic phase and 
spotted in ten fold dilutions on YPAD media. Subsequently, plates were incubated at 15 °C,  30 °C 













































Figure 4.4. Anisomycin and paromomycin  resistance phenotypes of L10 mutant strains. 
Strains harboring mutant alleles of ribosomal protein L10 were grown to mid-logarithmic phase and 
spotted in ten fold dilutions on media containing anisomycin (10 μg/ml), paromomycin (3 mg/ml), 
and control media without drug. Plates were subsequently incubated at 30 °C for three days and 
















































































































































WT N/A N/A N/A N/A P93S -0.5 0 +1 0
R7L 0 0 +2 0 P93T 0 0 0 0
R7P 0 0 +2 0 F94I 0 0 +2 0
R7Q 0 0 0 0 F94L 0 0 +1 0
Y9C 0 0 +1 0 I120T 0 0 +2 0
Y9H +1 0 -1 0 N144D 0 0 0 +1
Y9N 0 0 -1 0 K145E 0 0 0 0
Y11C 0 0 0 0 K145R 0 0 0 0
K15R 0 0 0 0 L152M 0 0 +1 0
Y17C +0.5 0 -1 0 P160T 0 0 0 0
V26D 0 0 +0.5 0 P179S 0 0 +2 0
K40M 0 0 +2 0 F199I 0 0 +1 0
K40R 0 0 0 0 S201F 0 0 0 0
Q59H 0 0 +3 0 K202Q 0 0 0 0
A64G 0 0 0 0 L206V 0 0 0 0
K74M 0 0 0 0 E207G 0 0 0 0
G81D 0 0 -0.5 -2 R211I 0 0 0 0  
 
Table 2. Temperature and drug sensitivity phenotypes of L10 mutants 
Positive values represent a resistance, while negative values represent sensitivity to a specific 
condition compared to its own and wild-type growth at 30 ºC on the media without drug. A value of 
0 indicates absence of specific phenotype. The values expressed as log10 difference as scored by 





 associated with formation of the codon-anticodon duplex 276,277. Interestingly, 
paromomycin improved the growth of the N144D allele (Figure 4.4). Only one 
paromomycin sensitive strain (G81D) was identified, which also promoted 
anisomycin sensitivity.  
Programmed -1 ribosomal frameshifting and nonsense suppression 
Altered efficiencies of  -1PRF is one of the common causes of the loss of the 
M1 virus and Killer phenotype. -1 PRF efficiencies were determined for the all of the 
new rpl10 alleles. Wild type level of -1PRF was 8.3 + 0.16%. Surprisingly most of 
the rpl10 alleles did not show significant changes in -1PRF efficiencies. Three alleles 
(K15R, K145E and P178S) promoted decreased levels of -1PRF, six alleles (Y9C, 
Y9H, Y11C, K74M, G81D and P93S) promoted increased levels of frameshifting, 
and 24 strains exhibited wild type efficiencies (Figure 4.6). Therefore, loss of the 
killer virus in most of the strains could not be attributed to the changes in -1PRF.  
Efficiency of non programmed nonsense codon suppression was measured in 
all rpl10 strains using the dual-luciferase system. The results are summarized in the 
Figure 4.7. The wild type level of nonsense suppression was determined to be 2.7 %. 
Among the mutants, 11 strains had elevated levels of nonsense suppression, and 7 
strains were hyper-accurate. The levels of nonsense suppression varied significantly 
between strains. The greatest level of NS was observed in the P179S mutant (2.2 fold 
of wild-type). The lowest levels were observed in the Y9C and F94I mutants (0.42- 

























Figure 4.5. Position of new rpl10 mutants in ternary ribosomal structure. 
Ribosomal protein L10 (green) is sandwiched between h38 and h89. The tip of  L10 contacts with 
h39 (blue) and P-loop (h80). The inner core of the peptidyl transferase center is represented by the 
red sticks models. Mutations in L10 that promote loss of the killer phenotype are shown as spheres. 














































































































Figure 4.6. -1PRF efficiencies of the new rpl10 alleles 
The library of rpl10 alleles was examined for efficiencies of -1PRF.  The -1PRF efficiency of wild-
type was 8.3 ± 0.16 %. The data are presented as fold of wild-type, and the error bars represent 
standard error.  Frameshifting efficiencies less than 0.8 and greater than 1.2 are considered as 












































































































Figure 4.7. Nonsense suppression efficiencies of new rpl10 alleles 
Nonsense suppression efficiencies were examined for the library of rpl10. The nonsense suppression 
efficiency of wild-type was 2.7 ± 0.11 %. The data are presented as fold of wild-type, and the error 





 nonsense suppression are closely clustered in the four regions of the protein: 7-17, 
81-94, 144-152, and 199-201. 
Biochemical characterization of the new rpl10 alleles 
Previous studies demonstrated an important role for L10 in large subunit 
maturation 264,266. Sucrose gradient analyses were performed on a subset of strains 
harboring L10 mutants to reveal their effects on ribosomal biogenesis. A total of 16 
strains were examined. This analysis revealed two types of effects. First, the R7L, 
R7Q, G81D, P93S, P93T, F94I, K145I, and K145R mutants demonstrated the 
presence of halfmers in their polysomal fractions (Figure 4.8).  The halfmers indicate 
the presence of initiation intermediates. During initiation, the 43S complex recruits 
the mRNA (thus forming 48S complex) and the 60S subunit. Insufficient 60S 
production or production of defective 60S subunits that are deficient in their ability to 
form 80S ribosomes pause initiation at the 48S complex stage. Accumulation of this 
intermediate is detected as halfmers on polysome profiles. The assembly of the 48S 
complexes on actively translated mRNAs results in formation of complexes with 
intermediate sedimentation coefficients relative to the polysome peaks. Second, 
strains Y9C, R7P and R7Q had reduced levels of 60S subunits, also indicating 60S 
biogenesis defect. Previous studies demonstrated that the N-terminal region of L10 is 
required for interaction with Sqt1p. Therefore, at least some of these mutants may 
affect later stages of ribosome biogenesis, e.g. interactions with Lsg1p and Nmd3p, or 
result in formation of partially active 60S ribosomal subunits. Notably, the extents of 





Figure 4.8. Sucrose gradient profiles of the L10 mutants strains 
Cell lysates were separated by centrifugation in a SW-41Ti rotor at 40000 rpm for 3 h at 4 °C. 
Gradients were subsequently developed using an ISCO-5 gradient fractionator. Continuous OD254 
readings were recorded and resulting hard copy charts were digitized. The red-ink curves were 
extracted using the color selection tool in Adobe Photoshop. The positions of the 40S, 60S, 80S and 
polysomal peaks are indicated on every profile. Halfmers may be seen as peaks immediately 




















































































































 rather than by position. For example, P93S promoted a severe halfmer defect, while 
the analogous substitution to threonine resulted in very mild defect. Similar results 
were observed for multiple mutations at positions 7, 9, 93 and 94 (Figure 4.8). 
The correlation observed in the L3 mutants (described in Chapter 2) between 
anisomycin resistance and increased affinity for A-site tRNA ecouraged us to 
characterize this parameter. Aminoacyl-tRNA association constants with the A-site 
were determined for ribosomes purified from five strains (WT, R7Q, Y9C, Y9H, and 
P93S). Strains were selected based on two criteria: first, by position in the ternary 
ribosomal structure, and secondly by their degree of anisomycin resistance. 
Interestingly, no direct correlation between anisomycin resistance and affinity for 
aminoacyl-tRNA was observed. The R7Q strain that does not exibit anisomycin 
dependent phenotype, and the anisomycin sensitive strain Y9H, had the same Ka as 
wild-type. One anisomycin resistant strain - P93S had an elevated affinity for the A-
site tRNA, but another resistant strain Y9C had a decreased Ka (Figure 4.9 and Table 
3).  
Discussion 
This study describes the generation and characterization of the library of rpl10 
alleles that promote loss of the Killer phenotype. Measurements of -1PRF 
demonstrated that loss of the killer is not due to changes in the -1PRF but rather due 
to the 60S biogenesis defect. However, mutants with seemingly normal polysome 
profiles and wild type levels of -1PRF suggested that killer virus loss can be 
promoted by another unknown mechanism. A similar observation was made with mak 
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Figure 4.9. Scatchard plot analysis of Phe-tRNA binding to ribosomes from the different rpl10 
strains. 
Aminoacyl-tRNA binding to the A-site of the ribosome was carried out as previously described 183. 
The reaction mixtures were preincubated with uncharged tRNA at 30°C for 15min to ensure full 
occupation of P- and E-sites by uncharged tRNA, after which various quantities of (4 – 264 pmoles) 
of [14C]Phe-tRNA were added. Reaction mixtures were incubated at 30 °C for an additional 15 
minutes to allow formation of [14C]Phe-tRNA-80S-poly(U) complexes. Aliquots were then applied 
onto nitrocellulose membranes, filters were washed with 2ml of binding buffer, and radioactivity 
was measured by scintillation counting. Background levels of radioactivity were determined using a 
blank sample and subtracted from the test samples. The A-site binding data was normalyzed to the 
amount of the active ribosomes, which was initially determined as intersection with the abscissa axis 










































WT 0.09 +/-0.01 1 1 N/A N/A N/A N/A No
R7Q 0.10 +/-0.04 0.98 +/-0.06 0.97 +/-0.06 0 0 0 0 -
Y9C 0.65 +/-0.14 1.34 +/-0.04 0.40 +/-0.01 +1 0 0 0 No
Y9H 0.11 +/-0.02 1.28 +/-0.04 0.71 +/-0.02 -1 0 +1 0 No
P93S 0.05 +/-0.01 1.40 +/-0.28 1.49 +/-0.48 +1 0 -0.5 0 Yes  
Table 3. Summary of properties of rpl10 mutants 
The -1PRF and nonsense suppression efficiencies expressed as a fold of wild type. Drug and 






The positions of the mutated residues in the 3-D ribosomal structure point to 
important components of L10 and critical regions of L10-ribosome interactions. The 
mutations were clustered in the regions of the protein that make contacts with helices 
89 and 38. Of the 22 mutant residues whose locations could be mapped in the 3-D 
ribosomal structure, 8 make contacts with h89 (R7L, R7P, R7Q, Y9C, Y9H, Y9N, 
Y11C and A64G) and 6 interact with h38 (K40M, K40R, P93S, P93T, F94I and 
F94L). Seven of these alleles were anisomycin resistant (R7L, R7P, Y9C, K40M, 
P93S, F94I, and F94L), and two were anisomycin sensitive (Y9H and Y9N). Notably, 
every mutant residue located near h89 either directly interacts with bases in the bulge 
at the base of h89 or makes contacts with residues of L10 that interact with the bulge 
(Figure 4.5). This bulge is involved in formation of the first of the “accommodation 
gates”, which are thought to direct movement of the acceptor end of the A-site tRNA 
during the accommodation stage of aa-tRNA selection 37.  The loop connecting h89 
and h90 forms the A-site side of the peptidyl transferase center and the anisomycin 
binding site (Figure 2.7).  Thus, these residues may affect both accommodation and 
the conformation of the peptidyl transferase center. As was previously observed with 
the mutants of rpl3, altered conformation of these gates was hypothesized to promote 
increased affinities for aminoacyl-tRNAs resulting in anisomycin resistance via a 
competitive mechanism. Notably, another cluster of L10 mutants (residues 93-94) 
interacts with h38, and in the ternary structure those mutants are close to the residues 
interacting with the h89. Thus, we hypothesized that this group of L10 mutants 
promote the observed anisomycin specific phenotypes through a similar competitive 
mechanism. To test this hypothesis, the aminoacyl-tRNA affinities for ribosomes 




and R7Q strains (no anisomycin phenotype), the anisomycin sensitive Y9H mutant, 
and the anisomycin resistant strain Y9C and P93S were examined. Ribosomes from 
R7Q strain have the same aa-tRNA affinities as wild type ribosomes, while ribosomes 
from the resistant mutant Y9C had a lower affinity for aa-tRNA, and ribosomes from 
the P93S resistant strain had increased affinity for aa-tRNA compared to wild type 
ribosomes. Lastly, ribosomes from the anisomycin sensitive Y9H strain were found to 
have the same affinity for the aa-tRNA as wild type (Table 3 and Figure 4.9). Thus, 
anisomycin resistance as applied to L10 is not linked with aa-tRNA affinity, implying 
that the mechanism of anisomycin resistance is different from that of L3. One 
alternative is that the rate of accomodation may be affected; however the effects 
could also be masked by altered efficiencies of the upstream reactions or by the 
changed stability of the ribosome-tRNA complex. For example, decreased rates of the 
initial aa-tRNA binding and (or) codon recognition could accompany the increased 
rates of accommodation.  Our tRNA binding assay measures “total” binding and is 
unable access the rates of the individual steps of the aa-tRNA selection. Thus the 
observed changes in aa-tRNA affinities may result from a combination of altered 
rates of accommodation and changes in the preceding steps. Alternatively, it is 
possible that these mutations affect the conformation of the anisomycin binding site, 
and thus the affinity of the ribosome for anisomycin. A similar effect was previously 
observed for tualimin and trichodermin 149,168. 
Previous analysis of an A-site finger (h38) deletion in E.coli demonstrated that 
the A-site finger is required for fine tuning of EF-G GTPase activation210 . Thus, the 
observed effects on aa-tRNA binding and anisomycin resistance may result from 




by assessing rates of the GTPase activation and GTP hydrolysis by the elongation 
factors eEF-1 and eEF-2. 
The current study also demonstrated effects of the L10 mutations on 
termination codon recognition. Altered levels of nonsense suppression suggest that 
these mutations: (A) may disrupt communication between the decoding center and the 
large subunit; or (B) may affect functions associated with release factors. 
Interestingly, two alleles, G81D and N144D, promoted a paromomycin specific 
phenotype. Paromomycin binds in the decoding center on the small subunit and 
promotes nonsense suppression. Notably, in the ternary ribosomal structure G81D 
and N144D are close to each other and are located on the solvent side of the 
ribosome. While no specific contacts between L10 and eEF-2 were observed in the 
Cryo-EM reconstruction of yeast ribosomes, that study did reveal a large unresolved 
"mass" composed of the tip of h38 and the C-terminal domain of L10 184. This "mass" 
contacts the L7/L12 stalk, which serves as an entry site for incoming translation 
factors. It is possible that conformational changes promoted by the G81D and N144D 
mutations are translated to the eEF-1 binding site, and thus may affect the fidelity of 
protein synthesis. Thus, the mutations near the solvent side of the ribosome may 
affect nonsense suppression by altering the ability of the ribosome to discriminate 
between elongation and termination factors. The proximity of this unresolved mass 
both to the elongation factor binding site and central protuberance suggests that L10 
may functionally connect the factor binding site and small subunit. Identification of 8 
mutants in this domain that promote Killer virus loss suggests a functional relevance 
of the C-terminus of L10. Notably, P179S, F199I, and S201F were hypoaccurate 




A recent study demonstrated an effect of the A-site finger on the level of stop 
codon read through 210. Thus, altered levels of nonsense suppression in L10 that 
establish contacts with h38 may result from altered A-site finger/L10 interactions. 
While it is currently unclear how mutations in L10 may cause such effects, the future 
structure probing experiment and biochemical characterization of the partial reactions 
of aminoacyl-tRNA selection and eRF1 binding may reveal the underlying 
mechanism (and structural prerequisites) of eRF1 recognition. Involvement of h38 in 
maintenance of the translational fidelity, as well as the position of the unresolved C-
terminal region of L10 between central protuberance and L7/L12 stalk, implies 
functional significance of h38. It is possible that h38 and L10 serve as a bridge 
between the factor binding site and the small subunit via the B1a bridge, or through 
the central protuberance. Alternatively, h38 may communicate with the h89 through 
L10, which forms a continious RNA structure with h90-92 and GTPase associated 
center (h42). Deletion of the h38 tip in E. coli resulted in decreased rates of EF-G 
activation, thus suggesting the possibility of a link between GTPase activation and B1 
bridge formation. Chemical probing of this region coupled with further biochemical 
characterization including monitoring of: (A) GTPase rates in these strains, and (B) 
the effects of codon-anticodon mismatching on rates of initial binding and codon 
recognition may further our understanding of the elongation factor function and role 
of the ribosome in aa-tRNA selection. 
L10 also plays the critical role in 60S subunit biogenesis. It is the last protein 
incorporated into the large ribosomal subunit, and is required for subunit joining and 
displacement of the export adapter Nmd3p. Thus, elucidation of these L10-associated 




subunit function and (or) activation, and (B) structural rearrangements that 
distinguish premature 60S subunits from active ribosomes. Recent studies 
demonstrated roles for Nmd3p, Sqt1p and Lsg1p in L10 incorporation, 60S export, 
and maturation 264,266. A subsequent study demonstrated that Arx1p and Rei1p are 
also involved in 60S export 278. However, the exact interplay between these factors is 
unknown. Further characterization of the L10 mutants with defects in ribosome 
biogenesis may shed light on these interactions and provide a deeper insight in the 
processes of ribosome maturation/activation. 
 
Here we have described random mutagenesis of ribosomal protein L10. 
The new rpl10 alleles were characterized with regard to cold, heat, anisomycin, 
and paromomycin associated phenotypes. Efficiencies of translational recoding 
events (-1PRF and NS) were measured using dual luciferase reporter systems. 
This characterization demonstrated that loss of the M1 virus is not due to 
changes in -1PRF efficiency. In a subset of strains, loss of the killer virus 
correlated with defects in subunit maturation and (or) joining, as evidenced by 
the presence of halfmers in sucrose gradient profiles. Further characterization of 
these strains may help to determine the sequence of events required for L10 
incorporation and (or) displacement of pNmd3, as well as activation of the large 
subunit. Biochemical characterization showed that anisomycin resistance in L10 
strains is not linked with changes in aa-tRNA affinity, and that the mechanism 




L3. Further characterization of these strains may help to unravel the functional 




Chapter 5. What is next? 
Further directions 
Genetic studies followed by functional/structural characterization are a proven 
approach for unraveling mechanisms of action of protein-RNA complexes. With 
regard to the results presented in this dissertation, we have presented functional 
analyses of ribosomal proteins L3 and L10, and 5S ribosomal rRNA. There are many 
possible directions along which this work can be extended, and multiple ways to test 
the proposed hypotheses. 
Ribosomal protein L3 
In this study, we proposed that accommodation triggers adoption of the active 
conformation by the peptidyl transferase center. There are few approaches that may 
be used to test this idea. First, since we proposed specific functions for the gate 
nucleotides (C2942, C2944 and C2943 in S. cerevisiae) and for the nucleotides that 
contact with tip of the L3, site specific mutagenesis of these bases may provide 
further insight into their functions. For example substitution of C2942 to U would 
prevent formation of the hydrogen bond between the primary amino group of C2942 
with the 2’ OH ribose of U2874 (in S. cerevisiae). Additionally, mutagenesis of the 
gate bases, for example purine to pyrimidine substitutions, would directly affect gate 
sizes, which should affect accommodation efficiency. Chemical modifications of 
these strains coupled with characterization of tRNA affinities for A- and P-sites, and 
rates of peptidyl transfer could provide help in determining their roles and interplay 




Biophysical experiments aimed toward directly examining the structural 
dynamics of the peptidyltransferase center would allow real time monitoring of 
changes in base conformation and flexibility. Fluorescent techniques have proved to 
be extremely useful in these types of analyses. One possible approach would be to use 
fluorescently labeled tRNA substrates and ribosomal components. Measurements of 
FRET, fluorescence half-lives, shifts in fluorescence parameters, etc. may provide 
insight into the conformational dynamics of the PTC during the process of 
accommodation and adoption of the “induced” state. There are a few potential targets 
for fluorescent labeling. Fluorescent labeling of A- and P-site tRNAs has been 
successfully used to determine the conformational transitions of the tRNAs during aa-
tRNA selection and translocation by FRET 60,279. Examination of PTC dynamics 
would be technically similar, and comparison of the mutant and wild type ribosomes 
may provide insight into the molecular mechanisms underlying the observed 
phenotypes. Fluorescence quenching is another method. It is based on notion that 
conformational changes in the immediate vicinity of a fluorophore may quench or 
brighten fluorescence. In the translation field this technique has been applied to 
observe conformational transitions in the D-loop of the tRNA upon binding with 
ribosomes 280,281. The introduction of the fluorophores (for example proflavine) into 
the acceptor end of the tRNA or 25S rRNA would enable real time monitoring of the 
conformational transitions around labeled bases. 
As a final thought, elucidation of the atomic resolution structures of these 
mutants in complex with different ligands (A- and P-site substrates and TSA analogs) 
would provide direct observation of structural roles of the C2942, C2944 and C2943 




would definitively describe the interplay between bases and amino acid residues of 
interest. 
5S rRNA 
The effects of naturally occurring allelic variants on the -1PRF efficiencies 
suggests that 5S rRNA may be involved in post transcriptional regulation of cellular 
gene expression via the NMD pathway. The plausibility of this hypothesis is based on 
the validity of the “mRNA suicide” idea. Thus a definitive demonstration of the role 
of -1PRF in regulation of bona fide cellular mRNA stability must necessarily precede 
attempts to reveal the physiological significance of 5S rRNA alleles on -1PRF 
efficiency. This could be achieved by monitoring of mRNA decay rates under 
conditions that promote different levels of -1PRF. These could be achieved by (A) 
using of NMD deficient strains (for example upf1∆), (B) using alleles of ribosomal 
components that promote altered levels of the frameshifting, and (C) using drugs that 
specifically affect -1PRF, i.e. anisomycin. 
Ribosomal protein L10 
In this work, we describe the generation and characterization of a library of 
rpl10 alleles. We have completed the initial analysis of these alleles, creating a 
toolbox for subsequent studies. There are multiple avenues that now may be followed 
with this project. First, strains with multiple defects in ribosome biogenesis were 
identified. Further characterization of these strains may help unravel the relationship 





Phenotypic and biochemical characterizations revealed that mechanism of 
anisomycin sensitivity/resistance is likely to be uncoupled from affinity for aa-tRNA. 
Pursuing this line of inquiry would contribute to furthering our understanding of 
ribosome function. Structural characterization of these mutants using RNA modifying 
agents will help to determine rRNA bases and structural groups affected by the L10 
mutants.  Site specific mutagenesis of 25S rRNA that interact with L10, specifically 
bulges in h89 and h38, may also shed light on their functions. Moreover, the bulge in 
helix 38 is a good candidate as a critical element involved in communication between 




Appendix A: Strains 
Table 4. List of strains used in the L3 study. 
Strain name Description 
5X47 MATa/MATα his1/+ trp1/+ ura3/+ K– 
JD1090 MATα ura3-52 lys2-801 trp1∆ leu2 his3 RPL3::HIS3 pJD166.ura 
[L-AHNB M1] 
JD1228 MATα ura3-52 lys2-801 trp1δ leu2= his3 RPL3::HIS3 
pJD166.WT.trp  
JD 1229 MATα ura3-52 lys2-801 trp1δ leu2= his3 RPL3::HIS3 
pJD166.mak8.trp 
JD1230 MATα ura3-52 lys2-801 trp1δ leu2= his3 RPL3::HIS3 
pJD166_P257T.trp 
JD1231 MATα ura3-52 lys2-801 trp1δ leu2= his3 RPL3::HIS3 
pJD166.I282T.trp 
JD1232 MATα ura3-52 lys2-801 trp1δ leu2= his3 RPL3::HIS3 
pJD166.W255C.trp 
JD1228.G15C MATα ura3-52 lys2-801 trp1δ leu2= his3 RPL3::HIS3 
pJD166.G15C.trp 






Table 5. List of strains used in the 5S study. 
Strain name Description 
5X47 MATa/MATα his1/+ trp1/+ ura3/+ K– 
JD759 MATα kar1-1 arg1 thr(i,x) L-A HN M1 
JD932D MATα ade 2-1 trp1-1 ura3-1 leu2-3,112 his3-11,15 can1-100  
[L-AHN M1] 
JD1111 MATa ade2-1 ura3-1 leu2-3 his3-11 trp1 can1-100 rdn1ΔΔ::HIS3 
pJD106.URA pJD211.LEU [LA-HN M1] 
JD1248 MATa ade2-1 ura3-1 trp1-1 his3-11 leu2-3, 112 can1-100 
∆rDNA::his3::hisG + pJD180.URA 
JD1253 MATa ade2-1 ura3-1 trp1-1 his3-11 leu2-3, 112 can1-100 
∆rDNA::his3::hisG + pJD180.URA [LA-HN M1] 
NOY1049  MATa ade2-1 ura3-1 trp1-1 his3-11 leu2-3, 112 can1-100 
∆rDNA::his3::hisG + pNOY353 (GAL7-35S rDNA, 5S rDNA, 






Table 6. List of strains used in the L10 study 
Strain name Description 
5X47 MATa/MATα his1/+ trp1/+ ura3/+ K– 
JD579 MATα kar1-1 arg1 thr(i,x) L-A HN M1 
JD1293 MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD429.URA,  L-A HN M1 
JD1308 MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 pJD586.HIS,  
L-A HN M1 
JD1308.R7L MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.R7L.HIS 
JD1308.R7P MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.R7P.HIS 
JD1308.R7Q MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.R7Q.HIS 
JD1308.Y9C MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.Y9C.HIS 
JD1308.Y9H MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.Y9H.HIS 
JD1308.Y9N MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.Y9N.HIS 
JD1308.Y11C MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.Y11C.HIS 
JD1308.K15R MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.K15R.HIS 
JD1308.Y17C MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.Y17C.HIS 
JD1308.V26D MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.V26D.HIS 
JD1308.K40M MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.K40M.HIS 
JD1308.K40R MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.K40R.HIS 
JD1308.Q59H MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.Q59H.HIS 
JD1308.A64G MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.A64G.HIS 
JD1308.K74M MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.K74M.HIS 
JD1308.G81D MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.G81D.HIS 
JD1308.P93S MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.P93S.HIS 
JD1308.P93T MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.P93T.HIS 





JD1308.F94L MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.F94L.HIS 
JD1308.I120T MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.I120T.HIS 
JD1308.N144D MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.N144D.HIS 
JD1308.K145E MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.K145E.HIS 
JD1308.K145R MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.K145R.HIS 
JD1308.L152M MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.L152M.HIS 
JD1308.P160T MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.P160T.HIS 
JD1308.P179S MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.P179S.HIS 
JD1308.F199I MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.F199I.HIS 
JD1308.S201F MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.S201F.HIS 
JD1308.K202Q MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.K202Q.HIS 
JD1308.L206V MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.L206V.HIS 
JD1308.F207G MATa rpl10::Kan met15∆0 leu2∆0 ura3∆0 his3∆0 
pJD586.F207G.HIS 







Appendix B: Plasmids 
Table 7. List of plasmids used in L3 study 
Plasmid name Parental vector Description 
pJD166 pRS316 282,283 A RPL3 expressing plasmid encoding wild 
type form of L3 from URA-based vector 158. 
pJD166.mak8-1 pJD166 A RPL3 expressing plasmid encoding mak8-
1 allele of L3 from Trp-based vector 158. 
pJD166.G15C pJD166 A RPL3 expressing plasmid encoding G15C 
allele of L3 from Trp-based vector. 
pJD166.P18S pJD166 A RPL3 expressing plasmid encoding P18S 
allele of L3 from Trp-based vector. 
pJD166.P257T pJD166 A RPL3 expressing plasmid encoding P257T 
allele of L3 from Trp-based vector 158. 
pJD166.W255C pJD166 A RPL3 expressing plasmid encoding 
W255C allele of L3 from Trp-based vector 
158. 
pJD166.I282T pJD166 A RPL3 expressing plasmid encoding I282T 






Table 8. List of reporter plasmids 
Plasmid 
name 
Parental vector Description 
pJEF1105  Ty1 retrotransposition reporter 
pJD170.0 pRS306 282,283 A zero frame monocistronic β- galactosidase 
reporter 
pJD179.-1 pRS306 A -1PRF (L-A frameshift signal) monocistronic 
β- galactosidase reporter 
pJD205.0 pRS305 282,283 A zero frame monocistronic β- galactosidase 
reporter  
pJD205.-1 pRS305 A -1PRF (L-A frameshift signal) monocistronic 
β- galactosidase reporter 
pJD205.+1 pRS305 A +1PRF (Ty1 frameshift signal) monocistronic 
β- galactosidase reporter 
   
pJD357 p2mc 284 A zero frame control dual luciferase reporter 
(DLR) expressing bicistronic mRNA encoding 
a fusion of Renilla and firefly luciferase 226. 
pJD376 p2mci 284 A -1PRF (L-A frameshift signal) dual luciferase 
reporter (DLR) expressing bicistronic mRNA 
encoding a fusion of Renilla and firefly 
luciferase 226 
pJD431 pJD357 A non-sense codon (UAA) suppression dual 
luciferase reporter (DLR) expressing bicistronic 






Table 9. List of plasmids harboring RDN alleles 
Plasmid name Parental 
vector 
Description 
pJD106.URA pRS426 282,283 pRS426 harboring wild-type allele of 5S rRNA 
pJD180.URA pRS426 pRS426 harboring wild-type alleles of 5S, 5.8S, 
18S and 25S rRNA 
pJD211.LEU pRS425 282,283 pRS425 harboring wild-type alleles of 5.8S, 
18S and 25S rRNA 
pJD373.LEU pRS425 pRS425 harboring wild-type alleles of 5.8S and 
25S, and Hygr (U1759C) allele of 18S rRNA 
pJD209 pRS424 282,283 pRS424 harboring wild-type allele of 5S rRNA 
pJD209.RDN5-
2 
pJD209 pJD209 harboring RDN5-2 allele of 5S rRNA 
pJD209.RDN5-
3 
pJD209 pJD209 harboring RDN5-3 allele of 5S rRNA 
pJD209.RDN5-
4 
pJD209 pJD209 harboring RDN5-4 allele of 5S rRNA 
pJD209.RDN5-
5 
pJD209 pJD209 harboring RDN5-5 allele of 5S rRNA 
pJD209.RDN5-
6 
pJD209 pJD209 harboring RDN5-6 allele of 5S rRNA 
pJD209.RDN5-
7 
pJD209 pJD209 harboring RDN5-7 allele of 5S rRNA 
pJD209.RDN5-
Ooc 





pJD209 pJD209 harboring RDN5-Som allele of 5S 
rRNA 
 
pJD209 pJD209 pJD209 harboring wild-type allele of 5S rRNA 
pJD209.G1A pJD209 pJD209 harboring G1A allele of 5S rRNA 
pJD209.G1U pJD209 pJD209 harboring G1U allele of 5S rRNA 
pJD209.G2A pJD209 pJD209 harboring G2A allele of 5S rRNA 
pJD209.G2U pJD209 pJD209 harboring G2U allele of 5S rRNA 
pJD209.G2C pJD209 pJD209 harboring G2C allele of 5S rRNA 
pJD209.U3A pJD209 pJD209 harboring U3A allele of 5S rRNA 
pJD209.U3C pJD209 pJD209 harboring U3C allele of 5S rRNA 
pJD209.U4A pJD209 pJD209 harboring U4A allele of 5S rRNA 
pJD209.U4C pJD209 pJD209 harboring U4C allele of 5S rRNA 
pJD209.G5A pJD209 pJD209 harboring G5A allele of 5S rRNA 
pJD209.G5U pJD209 pJD209 harboring G5U allele of 5S rRNA 
pJD209.G5C pJD209 pJD209 harboring G5C allele of 5S rRNA 
pJD209.C6A pJD209 pJD209 harboring C6A allele of 5S rRNA 
pJD209.C6U pJD209 pJD209 harboring C6U allele of 5S rRNA 
pJD209.G7U pJD209 pJD209 harboring G7U allele of 5S rRNA 




pJD209.G8A pJD209 pJD209 harboring G8A allele of 5S rRNA 
pJD209.G8U pJD209 pJD209 harboring G8U allele of 5S rRNA 
pJD209.G8C pJD209 pJD209 harboring G8C allele of 5S rRNA 
pJD209.C9U pJD209 pJD209 harboring C9U allele of 5S rRNA 
pJD209.C9G pJD209 pJD209 harboring C9G allele of 5S rRNA 
pJD209.C10A pJD209 pJD209 harboring C10A allele of 5S rRNA 
pJD209.C10U pJD209 pJD209 harboring C10U allele of 5S rRNA 
pJD209.A11C pJD209 pJD209 harboring A11C allele of 5S rRNA 
pJD209.A11G pJD209 pJD209 harboring A11G allele of 5S rRNA 
pJD209.U12C pJD209 pJD209 harboring U12C allele of 5S rRNA 
pJD209.A13C pJD209 pJD209 harboring A13C allele of 5S rRNA 
pJD209.U14A pJD209 pJD209 harboring U14A allele of 5S rRNA 
pJD209.U14C pJD209 pJD209 harboring U14C allele of 5S rRNA 
pJD209.C15A pJD209 pJD209 harboring C15A allele of 5S rRNA 
pJD209.C15U pJD209 pJD209 harboring C15U allele of 5S rRNA 
pJD209.U16A pJD209 pJD209 harboring U16A allele of 5S rRNA 
pJD209.U16C pJD209 pJD209 harboring U16C allele of 5S rRNA 
pJD209.A17C pJD209 pJD209 harboring A17C allele of 5S rRNA 
pJD209.C18U pJD209 pJD209 harboring C18U allele of 5S rRNA 
pJD209.C19A pJD209 pJD209 harboring C19A allele of 5S rRNA 
pJD209.C19U pJD209 pJD209 harboring C19U allele of 5S rRNA 
pJD209.C19G pJD209 pJD209 harboring C19G allele of 5S rRNA 
pJD209.A20C pJD209 pJD209 harboring A20C allele of 5S rRNA 
pJD209.A20G pJD209 pJD209 harboring A20G allele of 5S rRNA 
pJD209.G21A pJD209 pJD209 harboring G21A allele of 5S rRNA 
pJD209.G21U pJD209 pJD209 harboring G21U allele of 5S rRNA 
pJD209.DG21 pJD209 pJD209 harboring DG21 allele of 5S rRNA 
pJD209.A22U pJD209 pJD209 harboring A22U allele of 5S rRNA 
pJD209.A22C pJD209 pJD209 harboring A22C allele of 5S rRNA 
pJD209.A22G pJD209 pJD209 harboring A22G allele of 5S rRNA 
pJD209.A23U pJD209 pJD209 harboring A23U allele of 5S rRNA 
pJD209.A23C pJD209 pJD209 harboring A23C allele of 5S rRNA 
pJD209.A23G pJD209 pJD209 harboring A23G allele of 5S rRNA 
pJD209.A24U pJD209 pJD209 harboring A24U allele of 5S rRNA 
pJD209.A24C pJD209 pJD209 harboring A24C allele of 5S rRNA 
pJD209.G25A pJD209 pJD209 harboring G25A allele of 5S rRNA 
pJD209.G25U pJD209 pJD209 harboring G25U allele of 5S rRNA 
pJD209.G25C pJD209 pJD209 harboring G25C allele of 5S rRNA 
pJD209.C26U pJD209 pJD209 harboring C26U allele of 5S rRNA 
pJD209.A27C pJD209 pJD209 harboring A27C allele of 5S rRNA 
pJD209.A27G pJD209 pJD209 harboring A27G allele of 5S rRNA 
pJD209.C28A pJD209 pJD209 harboring C28A allele of 5S rRNA 
pJD209.C28U pJD209 pJD209 harboring C28U allele of 5S rRNA 
pJD209.C29A pJD209 pJD209 harboring C29A allele of 5S rRNA 
pJD209.C29U pJD209 pJD209 harboring C29U allele of 5S rRNA 
pJD209.G30A pJD209 pJD209 harboring G30A allele of 5S rRNA 




pJD209.G30C pJD209 pJD209 harboring G30C allele of 5S rRNA 
pJD209.U31A pJD209 pJD209 harboring U31A allele of 5S rRNA 
pJD209.U31C pJD209 pJD209 harboring U31C allele of 5S rRNA 
pJD209.U32A pJD209 pJD209 harboring U32A allele of 5S rRNA 
pJD209.U32C pJD209 pJD209 harboring U32C allele of 5S rRNA 
pJD209.U33A pJD209 pJD209 harboring U33A allele of 5S rRNA 
pJD209.U33C pJD209 pJD209 harboring U33C allele of 5S rRNA 
pJD209.U33G pJD209 pJD209 harboring U33G allele of 5S rRNA 
pJD209.C34A pJD209 pJD209 harboring C34A allele of 5S rRNA 
pJD209.C34G pJD209 pJD209 harboring C34G allele of 5S rRNA 
pJD209.C35U pJD209 pJD209 harboring C35U allele of 5S rRNA 
pJD209.C35G pJD209 pJD209 harboring C35G allele of 5S rRNA 
pJD209.DC36 pJD209 pJD209 harboring DC36 allele of 5S rRNA 
pJD209.C36A pJD209 pJD209 harboring C36A allele of 5S rRNA 
pJD209.C36U pJD209 pJD209 harboring C36U allele of 5S rRNA 
pJD209.C36G pJD209 pJD209 harboring C36G allele of 5S rRNA 
pJD209.G37A pJD209 pJD209 harboring G37A allele of 5S rRNA 
pJD209.G37U pJD209 pJD209 harboring G37U allele of 5S rRNA 
pJD209.G37C pJD209 pJD209 harboring G37C allele of 5S rRNA 
pJD209.U38A pJD209 pJD209 harboring U38A allele of 5S rRNA 
pJD209.U38C pJD209 pJD209 harboring U38C allele of 5S rRNA 
pJD209.U38G pJD209 pJD209 harboring U38G allele of 5S rRNA 
pJD209.C39A pJD209 pJD209 harboring C39A allele of 5S rRNA 
pJD209.C39U pJD209 pJD209 harboring C39U allele of 5S rRNA 
pJD209.C39G pJD209 pJD209 harboring C39G allele of 5S rRNA 
pJD209.C40A pJD209 pJD209 harboring C40A allele of 5S rRNA 
pJD209.C40U pJD209 pJD209 harboring C40U allele of 5S rRNA 
pJD209.C40G pJD209 pJD209 harboring C40G allele of 5S rRNA 
pJD209.G41A pJD209 pJD209 harboring G41A allele of 5S rRNA 
pJD209.G41U pJD209 pJD209 harboring G41U allele of 5S rRNA 
pJD209.G41C pJD209 pJD209 harboring G41C allele of 5S rRNA 
pJD209.A42C pJD209 pJD209 harboring A42C allele of 5S rRNA 
pJD209.U43C pJD209 pJD209 harboring U43C allele of 5S rRNA 
pJD209.U43G pJD209 pJD209 harboring U43G allele of 5S rRNA 
pJD209.C44A pJD209 pJD209 harboring C44A allele of 5S rRNA 
pJD209.C44U pJD209 pJD209 harboring C44U allele of 5S rRNA 
pJD209.A45U pJD209 pJD209 harboring A45U allele of 5S rRNA 
pJD209.A45C pJD209 pJD209 harboring A45C allele of 5S rRNA 
pJD209.A46U pJD209 pJD209 harboring A46U allele of 5S rRNA 
pJD209.A46C pJD209 pJD209 harboring A46C allele of 5S rRNA 
pJD209.C47A pJD209 pJD209 harboring C47A allele of 5S rRNA 
pJD209.C47U pJD209 pJD209 harboring C47U allele of 5S rRNA 
pJD209.C47G pJD209 pJD209 harboring C47G allele of 5S rRNA 
pJD209.U48A pJD209 pJD209 harboring U48A allele of 5S rRNA 
pJD209.U48C pJD209 pJD209 harboring U48C allele of 5S rRNA 
pJD209.G49A pJD209 pJD209 harboring G49A allele of 5S rRNA 




pJD209.U50A pJD209 pJD209 harboring U50A allele of 5S rRNA 
pJD209.U50C pJD209 pJD209 harboring U50C allele of 5S rRNA 
pJD209.A51U pJD209 pJD209 harboring A51U allele of 5S rRNA 
pJD209.A51C pJD209 pJD209 harboring A51C allele of 5S rRNA 
pJD209.G52A pJD209 pJD209 harboring G52A allele of 5S rRNA 
pJD209.G52C pJD209 pJD209 harboring G52C allele of 5S rRNA 
pJD209.U53A pJD209 pJD209 harboring U53A allele of 5S rRNA 
pJD209.U53C pJD209 pJD209 harboring U53C allele of 5S rRNA 
pJD209.U54A pJD209 pJD209 harboring U54A allele of 5S rRNA 
pJD209.U54C pJD209 pJD209 harboring U54C allele of 5S rRNA 
pJD209.A55U pJD209 pJD209 harboring A55U allele of 5S rRNA 
pJD209.A55C pJD209 pJD209 harboring A55C allele of 5S rRNA 
pJD209.A56C pJD209 pJD209 harboring A56C allele of 5S rRNA 
pJD209.G57A pJD209 pJD209 harboring G57A allele of 5S rRNA 
pJD209.G57U pJD209 pJD209 harboring G57U allele of 5S rRNA 
pJD209.G57C pJD209 pJD209 harboring G57C allele of 5S rRNA 
pJD209.C58U pJD209 pJD209 harboring C58U allele of 5S rRNA 
pJD209.C58G pJD209 pJD209 harboring C58G allele of 5S rRNA 
pJD209.U59A pJD209 pJD209 harboring U59A allele of 5S rRNA 
pJD209.U59C pJD209 pJD209 harboring U59C allele of 5S rRNA 
pJD209.G60A pJD209 pJD209 harboring G60A allele of 5S rRNA 
pJD209.G60U pJD209 pJD209 harboring G60U allele of 5S rRNA 
pJD209.G61A pJD209 pJD209 harboring G61A allele of 5S rRNA 
pJD209.G61U pJD209 pJD209 harboring G61U allele of 5S rRNA 
pJD209.G61C pJD209 pJD209 harboring G61C allele of 5S rRNA 
pJD209.U62C pJD209 pJD209 harboring U62C allele of 5S rRNA 
pJD209.A63U pJD209 pJD209 harboring A63U allele of 5S rRNA 
pJD209.A63C pJD209 pJD209 harboring A63C allele of 5S rRNA 
pJD209.A64U pJD209 pJD209 harboring A64U allele of 5S rRNA 
pJD209.A64C pJD209 pJD209 harboring A64C allele of 5S rRNA 
pJD209.G65U pJD209 pJD209 harboring G65U allele of 5S rRNA 
pJD209.A66G pJD209 pJD209 harboring A66G allele of 5S rRNA 
pJD209.G67A pJD209 pJD209 harboring G67A allele of 5S rRNA 
pJD209.G67C pJD209 pJD209 harboring G67C allele of 5S rRNA 
pJD209.C68U pJD209 pJD209 harboring C68U allele of 5S rRNA 
pJD209.C68G pJD209 pJD209 harboring C68G allele of 5S rRNA 
pJD209.C69A pJD209 pJD209 harboring C69A allele of 5S rRNA 
pJD209.C69U pJD209 pJD209 harboring C69U allele of 5S rRNA 
pJD209.C69G pJD209 pJD209 harboring C69G allele of 5S rRNA 
pJD209.U70A pJD209 pJD209 harboring U70A allele of 5S rRNA 
pJD209.U70C pJD209 pJD209 harboring U70C allele of 5S rRNA 
pJD209.G71A pJD209 pJD209 harboring G71A allele of 5S rRNA 
pJD209.G71U pJD209 pJD209 harboring G71U allele of 5S rRNA 
pJD209.G71C pJD209 pJD209 harboring G71C allele of 5S rRNA 
pJD209.A72C pJD209 pJD209 harboring A72C allele of 5S rRNA 
pJD209.C73A pJD209 pJD209 harboring C73A allele of 5S rRNA 




pJD209.C73G pJD209 pJD209 harboring C73G allele of 5S rRNA 
pJD209.C74A pJD209 pJD209 harboring C74A allele of 5S rRNA 
pJD209.C74U pJD209 pJD209 harboring C74U allele of 5S rRNA 
pJD209.G75A pJD209 pJD209 harboring G75A allele of 5S rRNA 
pJD209.G75U pJD209 pJD209 harboring G75U allele of 5S rRNA 
pJD209.A76U pJD209 pJD209 harboring A76U allele of 5S rRNA 
pJD209.A76C pJD209 pJD209 harboring A76C allele of 5S rRNA 
pJD209.A76G pJD209 pJD209 harboring A76G allele of 5S rRNA 
pJD209.G77U pJD209 pJD209 harboring G77U allele of 5S rRNA 
pJD209.G77C pJD209 pJD209 harboring G77C allele of 5S rRNA 
pJD209.U78C pJD209 pJD209 harboring U78C allele of 5S rRNA 
pJD209.A79U pJD209 pJD209 harboring A79U allele of 5S rRNA 
pJD209.G80U pJD209 pJD209 harboring G80U allele of 5S rRNA 
pJD209.G80C pJD209 pJD209 harboring G80C allele of 5S rRNA 
pJD209.U81C pJD209 pJD209 harboring U81C allele of 5S rRNA 
pJD209.G82A pJD209 pJD209 harboring G82A allele of 5S rRNA 
pJD209.G82C pJD209 pJD209 harboring G82C allele of 5S rRNA 
pJD209.U83C pJD209 pJD209 harboring U83C allele of 5S rRNA 
pJD209.A84U pJD209 pJD209 harboring A84U allele of 5S rRNA 
pJD209.A84C pJD209 pJD209 harboring A84C allele of 5S rRNA 
pJD209.A84G pJD209 pJD209 harboring A84G allele of 5S rRNA 
pJD209.G85A pJD209 pJD209 harboring G85A allele of 5S rRNA 
pJD209.G85U pJD209 pJD209 harboring G85U allele of 5S rRNA 
pJD209.U86A pJD209 pJD209 harboring U86A allele of 5S rRNA 
pJD209.U86C pJD209 pJD209 harboring U86C allele of 5S rRNA 
pJD209.G87A pJD209 pJD209 harboring G87A allele of 5S rRNA 
pJD209.G87C pJD209 pJD209 harboring G87C allele of 5S rRNA 
pJD209.G88U pJD209 pJD209 harboring G88U allele of 5S rRNA 
pJD209.G88C pJD209 pJD209 harboring G88C allele of 5S rRNA 
pJD209.G89A pJD209 pJD209 harboring G89A allele of 5S rRNA 
pJD209.G89C pJD209 pJD209 harboring G89C allele of 5S rRNA 
pJD209.U90C pJD209 pJD209 harboring U90C allele of 5S rRNA 
pJD209.G91A pJD209 pJD209 harboring G91A allele of 5S rRNA 
pJD209.G91U pJD209 pJD209 harboring G91U allele of 5S rRNA 
pJD209.G91C pJD209 pJD209 harboring G91C allele of 5S rRNA 
pJD209.A92U pJD209 pJD209 harboring A92U allele of 5S rRNA 
pJD209.A92C pJD209 pJD209 harboring A92C allele of 5S rRNA 
pJD209.C93A pJD209 pJD209 harboring C93A allele of 5S rRNA 
pJD209.C93U pJD209 pJD209 harboring C93U allele of 5S rRNA 
pJD209.C94A pJD209 pJD209 harboring C94A allele of 5S rRNA 
pJD209.C94U pJD209 pJD209 harboring C94U allele of 5S rRNA 
pJD209.A95U pJD209 pJD209 harboring A95U allele of 5S rRNA 
pJD209.A95C pJD209 pJD209 harboring A95C allele of 5S rRNA 
pJD209.U96A pJD209 pJD209 harboring U96A allele of 5S rRNA 
pJD209.U96C pJD209 pJD209 harboring U96C allele of 5S rRNA 
pJD209.A97C pJD209 pJD209 harboring A97C allele of 5S rRNA 




pJD209.C98U pJD209 pJD209 harboring C98U allele of 5S rRNA 
pJD209.C98G pJD209 pJD209 harboring C98G allele of 5S rRNA 
pJD209.G99A pJD209 pJD209 harboring G99A allele of 5S rRNA 
pJD209.G99U pJD209 pJD209 harboring G99U allele of 5S rRNA 
pJD209.C100U pJD209 pJD209 harboring C100U allele of 5S rRNA 
pJD209.G101A pJD209 pJD209 harboring G101A allele of 5S rRNA 
pJD209.G101C pJD209 pJD209 harboring G101C allele of 5S rRNA 
pJD209.A102U pJD209 pJD209 harboring A102U allele of 5S rRNA 
pJD209.A102C pJD209 pJD209 harboring A102C allele of 5S rRNA 
pJD209.A102G pJD209 pJD209 harboring A102G allele of 5S rRNA 
pJD209.A103U pJD209 pJD209 harboring A103U allele of 5S rRNA 
pJD209.A103C pJD209 pJD209 harboring A103C allele of 5S rRNA 
pJD209.A104U pJD209 pJD209 harboring A104U allele of 5S rRNA 
pJD209.A104G pJD209 pJD209 harboring A104G allele of 5S rRNA 
pJD209.C105A pJD209 pJD209 harboring C105A allele of 5S rRNA 
pJD209.C105U pJD209 pJD209 harboring C105U allele of 5S rRNA 
pJD209.C105G pJD209 pJD209 harboring C105G allele of 5S rRNA 
pJD209.U106A pJD209 pJD209 harboring U106A allele of 5S rRNA 
pJD209.U106C pJD209 pJD209 harboring U106C allele of 5S rRNA 
pJD209.C107A pJD209 pJD209 harboring C107A allele of 5S rRNA 
pJD209.C107U pJD209 pJD209 harboring C107U allele of 5S rRNA 
pJD209.C107G pJD209 pJD209 harboring C107G allele of 5S rRNA 
pJD209.A108U pJD209 pJD209 harboring A108U allele of 5S rRNA 
pJD209.A108C pJD209 pJD209 harboring A108C allele of 5S rRNA 
pJD209.G109A pJD209 pJD209 harboring G109A allele of 5S rRNA 
pJD209.G109C pJD209 pJD209 harboring G109C allele of 5S rRNA 
pJD209.G110A pJD209 pJD209 harboring G110A allele of 5S rRNA 
pJD209.G110U pJD209 pJD209 harboring G110U allele of 5S rRNA 
pJD209.G110C pJD209 pJD209 harboring G110C allele of 5S rRNA 
pJD209.U111C pJD209 pJD209 harboring U111C allele of 5S rRNA 
pJD209.G112C pJD209 pJD209 harboring G112C allele of 5S rRNA 
pJD209.C113U pJD209 pJD209 harboring C113U allele of 5S rRNA 
pJD209.U114C pJD209 pJD209 harboring U114C allele of 5S rRNA 
pJD209.G115A pJD209 pJD209 harboring G115A allele of 5S rRNA 
pJD209.G115U pJD209 pJD209 harboring G115U allele of 5S rRNA 
pJD209.C116A pJD209 pJD209 harboring C116A allele of 5S rRNA 
pJD209.C116U pJD209 pJD209 harboring C116U allele of 5S rRNA 
pJD209.A117U pJD209 pJD209 harboring A117U allele of 5S rRNA 
pJD209.A117C pJD209 pJD209 harboring A117C allele of 5S rRNA 
pJD209.A118U pJD209 pJD209 harboring A118U allele of 5S rRNA 
pJD209.A118C pJD209 pJD209 harboring A118C allele of 5S rRNA 
pJD209.U119C pJD209 pJD209 harboring U119C allele of 5S rRNA 
pJD209.C120U pJD209 pJD209 harboring C120U allele of 5S rRNA 





Table 10. List of plasmids harboring RPL10 alleles 
Plasmid name Parental 
vector 
Description 
pJD429 pRS426 pRS426 harboring wild-type allele of RPL10 
pJD589 pRS313 282,283 pRS313 harboring wild-type allele of RPL10 
pJD589.R7L pJD589 pRS313 harboring R7L allele of RPL10 
pJD589.R7P pJD589 pRS313 harboring R7P allele of RPL10 
pJD589.R7Q pJD589 pRS313 harboring R7Q allele of RPL10 
pJD589.Y9C pJD589 pRS313 harboring Y9C allele of RPL10 
pJD589.Y9H pJD589 pRS313 harboring Y9H allele of RPL10 
pJD589.Y9N pJD589 pRS313 harboring Y9N allele of RPL10 
pJD589.Y11C pJD589 pRS313 harboring Y11C allele of RPL10 
pJD589.K15R pJD589 pRS313 harboring K15R allele of RPL10 
pJD589.Y17C pJD589 pRS313 harboring Y17C allele of RPL10 
pJD589.V26D pJD589 pRS313 harboring V26D allele of RPL10 
pJD589.K40M pJD589 pRS313 harboring K40M allele of RPL10 
pJD589.K40R pJD589 pRS313 harboring K40R allele of RPL10 
pJD589.Q59H pJD589 pRS313 harboring Q59H allele of RPL10 
pJD589.A64G pJD589 pRS313 harboring A64G allele of RPL10 
pJD589.K74M pJD589 pRS313 harboring K74M allele of RPL10 
pJD589.G81D pJD589 pRS313 harboring G81D allele of RPL10 
pJD589.P93S pJD589 pRS313 harboring P93S allele of RPL10 
pJD589.P93T pJD589 pRS313 harboring P93T allele of RPL10 
pJD589.F94I pJD589 pRS313 harboring F94I allele of RPL10 
pJD589.F94L pJD589 pRS313 harboring F94L allele of RPL10 
pJD589.I120T pJD589 pRS313 harboring I120T allele of RPL10 
pJD589.N144D pJD589 pRS313 harboring N144D allele of RPL10 
pJD589.K145E pJD589 pRS313 harboring K145E allele of RPL10 
pJD589.K145R pJD589 pRS313 harboring K145R allele of RPL10 
pJD589.L152M pJD589 pRS313 harboring L152M allele of RPL10 
pJD589.P160T pJD589 pRS313 harboring P160T allele of RPL10 
pJD589.P179S pJD589 pRS313 harboring P179S allele of RPL10 
pJD589.F199I pJD589 pRS313 harboring F199I allele of RPL10 
pJD589.S201F pJD589 pRS313 harboring S201F allele of RPL10 
pJD589.K202Q pJD589 pRS313 harboring K202Q allele of RPL10 
pJD589.L206V pJD589 pRS313 harboring L206V allele of RPL10 
pJD589.F207G pJD589 pRS313 harboring F207G allele of RPL10 





Appendix C: Primers 
Table 11. List of primers used in structure probing experiments . 





















Table 12. Primers used for direct sequencing of 5S rRNA.  


























































































































 Table 13. List of primers used for random mutagenesis of RPL10 
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